cytarabine and Leukemia, Promyelocytic, Acute

cytarabine has been researched along with Leukemia, Promyelocytic, Acute in 314 studies

Research

Studies (314)

Timeframe	Studies, this research(%)	All Research%
pre-1990	26 (8.28)	18.7374
1990's	121 (38.54)	18.2507
2000's	94 (29.94)	29.6817
2010's	66 (21.02)	24.3611
2020's	7 (2.23)	2.80

Authors

Authors	Studies
Feng, R; Li, J; Liu, H; Ning, S; Pei, L; Sun, J; Wang, T; Xing, B; Zhao, Y; Zhu, X	1
Ahn, MJ; Bae, SH; Bang, SM; Cho, EK; Choi, JH; Chong, SY; Hyun, MS; Jo, DY; Kim, B; Kim, BS; Kim, CS; Kim, DY; Kim, H; Kim, HJ; Kim, HS; Kim, I; Kim, SH; Kwon, H; Lee, JH; Lee, KH; Lee, MH; Lee, WS; Min, YJ; Moon, HN; Mun, YC; Nam, SH; Oh, D; Park, JH; Park, KT; Park, SY; Park, YH; Ryoo, HM; Seo, JJ; Seong, CM; Yoon, HJ; Yoon, SS; Zang, DY	1
Cao, H; Chen, S; Chen, Y; Dai, Y; Fan, J; Fang, Y; Gao, C; Gao, J; Han, Y; Hu, Q; Huang, P; Jin, J; Ju, X; Li, J; Liang, C; Liang, H; Lin, L; Lin, W; Liu, A; Liu, W; Peng, X; Peng, Y; Qi, P; Shao, J; Shi, X; Tian, X; Wang, J; Wang, L; Wang, T; Wang, X; Wang, Y; Wu, Y; Xiong, H; Xu, L; Yan, M; Yang, L; Yu, H; Yu, J; Zhai, X; Zhang, J; Zhang, L; Zhang, R; Zhang, Y; Zhao, W; Zheng, H; Zhou, M	1
Chan, SY; Dang, CC; Guan, YK; Lau, NS	1
Cangini, D; Cerchione, C; Ghelli Luserna Di Rorà, A; Giannini, MB; Gottardi, M; Martinelli, G; Padella, A; Simonetti, G; Sperotto, A	1
He, J; Wang, L; Yan, X	1
DiNardo, CD; Kadia, TM; Kantarjian, HM; Ravandi, F; Welch, MA	1
Alonzo, TA; Feusner, JH; Fu, CH; Gamis, AS; Gerbing, RB; Gregory, JJ; Hirsch, BA; Kutny, MA; Meshinchi, S; Raimondi, SC; Wang, YC	1
Berdel, WE; Bormann, E; Braess, J; Büchner, T; Flasshove, M; Görlich, D; Haferlach, C; Hecht, A; Hiddemann, W; Hofmann, WK; Horst, HA; Kreuzer, KA; Krug, U; Lengfelder, E; Lindemann, HW; Nowak, D; Sauerland, C; Schiel, X; Schliemann, C; Schneider, S; Schnittger, S; Spiekermann, K; Wörmann, B	1
An, W; Chang, L; Chen, X; Chen, Y; Guo, Y; Liu, F; Liu, T; Liu, X; Qi, B; Ren, Y; Ruan, M; Wang, S; Yang, W; Zhang, J; Zhang, L; Zhu, X; Zou, Y	1
Gale, RE; Garbowski, M; Khwaja, A; Linch, DC; Loddo, M; Sellar, RS; Stoeber, K; Williams, GH	1
Hu, LN; Li, GQ; Lin, HQ; Shen, Q; Sun, XF; Zhang, XY; Zhou, JH	1
Feusner, JH; Geyer, S; Gregory, J; Kutny, MA; Larson, RA; Laumann, KM; Powell, BL; Stock, W; Willman, CL	1
Afsar, NA; Kulsoom, B; Shamsi, TS	1
Atsuta, Y; Emi, N; Fujimaki, K; Fujisawa, S; Fujita, H; Kobayashi, Y; Maeda, A; Miyazaki, Y; Naoe, T; Ohtake, S; Ohwada, A; Sunami, K; Takeshita, A; Taniwaki, M; Tsuboi, K; Tsuzuki, M; Yanada, M	1
Adès, L; Cassinat, B; Chevret, S; Chomienne, C; de Botton, S; Deconinck, E; Degos, L; Dombret, H; Fenaux, P; Ferrant, A; Guerci-Bresler, A; Huguet, F; Lambert, JF; Lamy, T; Lioure, B; Pigneux, A; Quesnel, B; Raffoux, E; Thomas, X; Vekhoff, A; Vey, N	1
Duan, Y; Nie, J; Shang, W; Zhang, H; Zhang, Z; Zhou, L; Zhu, F; Zhu, H	1
Creutzig, U; Dworzak, MN; Reinhardt, D; Ritter, J; Schellong, G; Zimmermann, M	1
Bennett, D; Drago, MJ; Elder, D; Kim, BS; Rosenbach, M	1
Abe, T; Arihara, Y; Fujii, S; Fujita, M; Hirako, T; Jyomen, W; Kato, J; Kuroda, H; Maeda, M; Sakurai, T; Yamada, M	1
Huang, J; Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Tong, H; Tong, Y	1
Bo, Q; Cui, J; Ge, X; Hong, M; Hong, X; Jiang, X; Liu, J	1
Asou, N; Emi, N; Horikawa, K; Iwanaga, M; Kimura, Y; Kishimoto, Y; Kiyoi, H; Matsuda, M; Monma, F; Nakaseko, C; Naoe, T; Ohtake, S; Okada, M; Ono, T; Shinagawa, K; Takahashi, M; Takeshita, A; Yamauchi, T	1
Beyer, F; Franke, M; Persigehl, T; Theurich, S	1
Miyawaki, S	1
Altman, JK; Appelbaum, FR; Attar, EC; Coutre, SE; Gore, SD; Kopecky, KJ; Larson, RA; Levitan, D; Maher, T; Othus, M; Paietta, E; Powell, B; Stock, W; Tallman, MS; Wetzler, M; Willman, CL	1
Iland, HJ; Seymour, JF; Wei, A	1
Avvisati, G; Breccia, M; Carmosino, I; Chisini, M; Cimino, G; Colafigli, G; Finsinger, P; Foà, R; Girmenia, C; Latagliata, R; Lo-Coco, F; Minotti, C; Montagna, C; Petti, MC; Romano, A; Volpicelli, P; Vozella, F	1
Chen, RL; Huang, BT; Li, BS; Zeng, QC; Zhao, WH	1
Ravandi, F	1
Falsafi, M; Mansouri, K; Shahabadi, N	1
Adachi, S; Horibe, K; Iwamoto, S; Kinoshita, A; Koike, K; Kosaka, Y; Kudo, K; Matsushita, H; Miyachi, H; Moritake, H; Nakahata, T; Nakayama, H; Ogawa, A; Saito, AM; Shimada, A; Taga, T; Takahashi, H; Taki, T; Tawa, A; Terui, K; Tomizawa, D; Watanabe, T; Yabe, M; Yamashita, Y; Yuza, Y	1
Chen, D; Du, XH; Jin, J; Liu, XH; Lu, Y; Ma, JX; Pei, RZ; Si, T; Ye, PP; Zhang, PS	1
Ferenchak, K; Papakostas, TD; Vavvas, D	1
Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Wang, YP; Xue, HL; Ye, QD; Zhou, M	1
Au, WY; Fong, BM; Kwong, YL; Tam, S	1
Tallman, MS	2
Bernhaus, A; Fritzer-Szekeres, M; Graser, G; Grusch, M; Horvath, Z; Jaeger, W; Ozsvar-Kozma, M; Pemberger, M; Saiko, P; Savinc, I; Szekeres, T	1
Allen-Bard, S; Carlin, R; Christos, PJ; Curcio, T; Feldman, EJ; Mathew, S; Mazumdar, M; Provenzano, J; Ritchie, EK; Roboz, GJ; Samuel, M; Wittenberg, B	1
Bridger, G; DiPersio, JF; Holt, MS; Ley, TJ; Nervi, B; Piwnica-Worms, D; Prior, JL; Ramirez, P; Rettig, MP; Ritchey, JK; Uy, GL	1
Kassam, A; Mandel, K	1
Altman, JK; Tallman, MS	1
Guan, XQ; Huang, LB; Ke, ZY; Luo, XQ; Zhang, XL; Zhang, YC	1
Betancourt-García, RD; Castro, J; Fernández, AC; Fradera, J; López-Enríquez, A; Pacheco, E	1
Biondi, A; Rizzari, C	1
Aul, C; Berdel, WE; Braess, J; Büchner, T; Grüneisen, A; Haferlach, C; Haferlach, T; Hehlmann, R; Heinecke, A; Hiddemann, W; Kern, W; Lengfelder, E; Ludwig, WD; Reichle, A; Sauerland, MC; Saussele, S; Schnittger, S; Schultheis, B; Serve, H; Spiekermann, K; Staib, P; Wörmann, B	1
Alonzo, T; Appelbaum, F; Feusner, J; Gerbing, R; Gregory, J; Kim, H; Rowe, J; Schiffer, C; Shepherd, L; Tallman, M; Weinstein, H; Wiernik, P; Willman, C; Woods, W	1
Matsumura, I	1
Ammar, F; Azghari, A; Bensaid, Y; Boayad, M; Boukhbrine, MK; Bouziane, Z; El Mesnaoui, A; Idrissi, R; Lekehal, B; Sefiani, Y; Tijani, Y	1
Burnett, AK; Gale, RE; Gilkes, A; Goldstone, AH; Green, C; Guy, C; Hills, RK; Jenkinson, S; Koo, K; Linch, DC; Milligan, DW; Patel, Y; Prentice, AG; Wheatley, K	1
Collins, C; Knoderer, H	1
Kakimoto, T; Matsuzawa, M; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Takahashi, Y; Watanabe, H; Yoshida, S	1
Adès, L; Bordessoule, D; Cahn, JY; Castaigne, S; Chevallier, P; Chevret, S; de Botton, S; Degos, L; Dombret, H; Fegeux, N; Fenaux, P; Ferrant, A; Gardin, C; Guerci, A; Ifrah, N; Lapusan, S; Meyer-Monard, S; Raffoux, E; Rayon, C; Recher, C; Sanz, M; Solary, E; Thomas, X; Tournilhac, O; Vey, N	1
Arbitrario, JP; Fox, JA; Hawtin, RE; Howlett, AR; Kumer, JL; Scatena, CD; Silverman, JA	1
Arceci, R; Dauses, T; Devetten, M; Gallagher, RE; Gojo, I; Gore, SD; Jamieson, K; Morris, L; Owoeye, I; Redner, RL; Schachter-Tokarz, E; Sekeres, MA	1
Bourquin, JP; Creutzig, U; Dworzak, M; Henze, G; Kremens, B; Lakomek, M; Reinhardt, D; Stary, J; Urban, C; Zimmermann, M	1
Adès, L; Fenaux, P	2
Blinder, R; Chang, P; Galinsky, I; Ho, VT; Housman, E; Kesari, S; Lane, SW; Mullally, A; Stone, RM	1
Bakir, T; Bektaş, A; Cakar, B; Turgut, M; Ustaoğlu, M	1
Gill, D; Keane, C; Marlton, P; Mollee, P	1
Amadori, S; Avvisati, G; Borlenghi, E; Bosi, A; Breccia, M; Carella, AM; Cimino, G; Di Bona, E; Di Raimondo, F; Diverio, D; Fabbiano, F; Fazi, P; Ferrara, F; Fioritoni, G; Gallo, E; Lo-Coco, F; Mandelli, F; Martinelli, G; Paoloni, F; Peta, A; Petti, MC; Pogliani, EM; Rambaldi, A; Specchia, G; Vignetti, M	1
Dong, D; Fei, J; Gu, J; Hu, H; Li, Y; Lin, C; Yao, J; Zhu, X	1
Appelbaum, FR; Couban, S; Coutre, S; Feusner, JH; Gallagher, RE; Gregory, J; Larson, RA; Moser, B; Powell, BL; Rowe, JM; Stock, W; Stone, RM; Tallman, MS; Willman, CL	1
Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M	1
Hamamoto, K; Hanada, R; Horibe, K; Imaizumi, M; Kigasawa, H; Kobayashi, R; Kudo, K; Morimoto, A; Nakayama, H; Tabuchi, K; Tawa, A; Tsuchida, M; Tsuchiya, S; Tsukimoto, I; Yabe, H	1
Appelbaum, FR; Bennett, JM; Bloomfield, CD; de la Serna, J; Deben, G; Feusner, JH; Gallagher, R; Gonzalez, J; Gonzalez, M; Kim, HT; Larson, RA; Miguel, JD; Milone, G; Montesinos, P; Paietta, E; Rayon, C; Rivas, C; Rowe, JM; Sanz, MA; Schiffer, CA; Shepherd, L; Slack, JL; Tallman, MS; Vellenga, E; Wiernik, PH; Willman, CL	1
Chen, X; Chen, Y; Zhang, L; Zhu, X; Zou, Y	1
Cho, B; Jung, JY; Lee, DS; Lee, GY; Oh, IH; Shim, JS	1
Lo-Coco, F; Sanz, MA	1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Marui, Y; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Takemoto, F; Tsuchiya, Y; Ubara, Y; Yamanouchi, M	1
Abellán, PF; Arnan, M; de Llano, MP; Duarte, RF; Sánchez-Ortega, I	1
Chen, DQ; Chen, L; He, JX; Miao, ZH; Shen, JK; Wang, X	1
Avvisati, G; Breccia, M; Candoni, A; Cimino, G; Di Raimondo, F; Fazi, P; Kropp, MG; Latagliata, R; Lo-Coco, F; Mandelli, F; Martinelli, G; Melillo, L; Petti, MC; Rupoli, S; Salvi, F; Sborgia, M; Tonso, A; Venditti, A; Vignetti, M; Vincelli, D	1
Aoki, A; Miyazono, T; Saito, S; Sugiyama, T; Yoneda, N; Yoneda, S	1
Akashi, K; Harada, M; Kamimura, T; Miyamoto, T	1
Au, WY; Kumana, CR; Kwong, YL; Lau, JS; Lee, HK; Lin, SY; Liu, H; Yeung, DY	1
Gurung, A; Huang, BT; Li, BS; Xiao, Z; Zeng, QC; Zhao, WH	1
Bai, QX; Chen, XQ; Gao, GX; Gu, HT; Liang, R; Shu, MM; Wang, WQ; Wang, YW; Yang, L; Zhang, T; Zhang, YQ; Zhu, HF	1
Mi, J	1
Bai, H; Cao, Z; Deng, C; Wang, C; Zhou, L	1
Chen, Y; Li, Z; Lu, Q	1
Asou, N; Horikawa, K; Iwanaga, M; Kimura, Y; Kishimoto, Y; Kiyoi, H; Matsuda, M; Monma, F; Nakaseko, C; Naoe, T; Ohtake, S; Okada, M; Ono, T; Shinagawa, K; Takahashi, M; Takeshita, A; Tsuzuki, M; Yamauchi, T	1
Anabuki, K; Arakawa, Y; Ikezoe, T; Isaka, M; Iwabu, N; Kin, T; Sakai, M; Takeuchi, A; Taniguchi, A; Togitani, K; Yokoyama, A	1
Appelbaum, FR; Burnett, AK; Estey, EH; Kantarjian, HM; Larson, RA; Lo-Coco, F; Ravandi, F; Schiffer, CA	1
Aul, C; Berdel, WE; Braess, J; Büchner, T; Erben, P; Haferlach, C; Haferlach, T; Hanfstein, B; Hehlmann, R; Heinecke, A; Hiddemann, W; Hofmann, WK; Horst, HA; Kreuzer, KA; Krug, U; Lengfelder, E; Müller-Tidow, C; Sauerland, C; Schneider, S; Schnittger, S; Schultheis, B; Serve, H; Spiekermann, K; Wörmann, B	1
Bruserud, Ø; Gjertsen, BT; McCormack, E; Mujić, M; Osdal, T	1
Elford, HL; Fritzer-Szekeres, M; Grusch, M; Höchtl, T; Horvath, Z; Jäger, W; Krupitza, G; Salamon, A; Steinbrugger, R; Szekeres, T	1
Bogdanovic, A; Colovic, M; Colovic, N; Jankovic, G; Miljic, P	1
Amadori, S; Avvisati, G; Baccarani, M; Cantore, N; Di Bona, E; Ferrara, F; Fioritoni, G; Gallo, E; Invernizzi, R; Lazzarino, M; Liso, V; Lo-Coco, F; Mandelli, F; Mariani, G; Petti, MC; Ricciuti, F; Selleri, C; Sica, S; Vegna, ML; Veneri, D	1
Andersen, JW; Appelbaum, FR; Bloomfield, CD; Feusner, JH; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Weinstein, H; Wiernik, PH; Willman, C; Woods, WG	1
Higashihara, M; Honma, Y; Niitsu, N	1
Soda, R; Takahashi, K; Takeuchi, M; Ueda, T; Yamauchi, T; Yoshida, I	1
Flanagan, SA; Meckling, KA	1
Chang, CS; Chung, CY; Horng, HC; Hsu, NC	1
Itoh, M; Shimada, H; Takao, S; Yago, K	1
Bordessoule, D; Chevret, S; Chomienne, C; Degos, L; Desablens, B; Fenaux, P; Ferrant, A; Fey, M; Lobe, I; Mounier, C; Rigal-Huguet, F; Sanz, M; Vekhoff, A	1
Goede, A; Kalk, E; Rose, P	1
Fujisawa, S; Fujita, H; Hyo, R; Ishigatsubo, Y; Kanamori, H; Koharazawa, H; Takemura, S; Tanaka, M	1
Udvardy, M	1
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR	1
Kondo, T; Mikami, M; Nakanishi, H; Otsuki, T; Suemori, S; Suetsugu, Y; Sugihara, T; Tsujioka, T; Wada, H; Yamamori, S	1
Fouillard, L; Frassoni, F; Gorin, NC; Labopin, M; Meloni, G; Polge, E	1
Ueda, T	1
Baruchel, A; Bordessoule, D; Chevret, S; Chomienne, C; Coiteux, V; Conde, E; de Botton, S; de La Serna, J; Degos, L; Fegueux, N; Fenaux, P; Fey, M; Leverger, G; Parry, A; Philippe, N; Rayon, C; Robert, A; San Miguel, J; Sanz, M; Sotto, JJ; Vilmer, E	1
Iguchi, A; Kobayashi, K; Kobayashi, R; Nakajima, M; Sato, T	1
Baker, RJ; Burgess, M; Ethell, M; Ganeshaguru, K; Gerrard, G; Jones, DT; McCullough, H; Mehta, AB; Payne, E; Potter, M; Prentice, HG	1
Aleksanian, MZh; Anchukova, LV; Demidova, IA; Domracheva, EV; Filatov, LB; Gribanova, EO; Isaev, VG; Kaplanov, K; Khoroshko, ND; Konstantinova, TS; Kravchenko, SK; Lapin, VA; Mashuk, VN; Miliutina, GI; Misiurin, AV; Ol'shanskaia, IuV; Parovichnikova, EN; Perekatova, TN; Pristupa, AS; Rekhtman, GB; Savchenko, VG; Shuravina, EN; Sokolova, I; Sviridova, EI; Ustinova, EN; Volkova, SA; Zagoskina, TP; Ziuzgin, IS	1
Chandy, M; George, B; Poonkuzhali, B; Srivastava, A; Srivastava, VM	1
Bayraktaroglu, T; Borazan, A; Demircan, N; Ozdemir, H; Ozer, T; Savranlar, A; Ustündag, Y	1
Bai, LY; Chao, TC; Chen, PM; Teng, HW; Wang, WS	1
Bauer, W; Erker, T; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Illmer, C; Jaeger, W; Madlener, S; Saiko, P; Szekeres, T	2
Benner, A; del Valle y Fuentes, F; Döhner, H; Döhner, K; Fischer, JT; Fröhling, S; Germing, U; Glasmacher, A; Götze, K; Grimminger, W; Hartmann, F; Hensel, M; Nerl, C; Petzer, A; Pralle, H; Salwender, H; Schlenk, RF; Zick, L	1
Avvisati, G; Breccia, M; Capria, S; Cimino, G; Diverio, D; Latagliata, R; Meloni, G; Petti, MC	1
Cedrone, M; Chierichini, A; Diverio, D; Foà, R; Lo Coco, F; Mariani, G; Pasquini, L; Pelosi, E; Peschle, C; Riccioni, R; Rossini, A; Saulle, E; Testa, U; Vitale, A	1
Furukawa, H; Iguchi, A; Kobayashi, K; Kobayashi, R; Koizumi, S; Nakajima, M; Sato, T; Todoh, S	1
Buerger, AU; Fey, MF; Garamvoelgyi, EM; Mueller, BU; Oppliger-Leibundgut, E; Pabst, T; Solenthaler, M	1
Amaya, N; Arai, H; Lee, JD; Taga, M; Ueda, T; Yamauchi, T	1
Forrest, DL; Hogge, DE; Lavoie, JC; Nantel, SH; Nevil, TJ; Savoie, ML; Shepherd, JD; Smith, CA; Song, KW; Sutherland, HJ; Toze, CL	1
Dubrulle, S; Faussat, AM; Legrand, O; Majdak, P; Marie, JP; Marjanovic, Z; Marzac, C; Tang, R	1
Baer, MR; Barcos, M; Finlay, E; Pawarode, A; Sait, SN	1
Brandalise, SR; Matsuda, EI; Nowill, AE; Oliveira, SN; Rodrigues, PC; Viana, MB; Yunes, JA	1
Duan, LN; Guo, ZK; Ji, SQ; Wang, HX	1
Akaike, H; Kawasaki, K; Miyauchi, A; Ouchi, K	1
Erker, T; Fritzer-Szekeres, M; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Krupitza, G; Madlener, S; Murias, M; Saiko, P; Szekeres, T	1
Erker, T; Fritzer-Szekeres, M; Handler, N; Horvath, Z; Jaeger, W; Murias, M; Saiko, P; Szekeres, T	1
Baer, MR; Minderman, H; O'Loughlin, KL; Zhou, Y	1
Adès, L; Chevret, S; Chomienne, C; de Botton, S; Deconinck, E; Degos, L; Dombret, H; Fegueux, N; Fenaux, P; Ferrant, A; Guerci, A; Lamy, T; Maloisel, F; Meyer-Monard, S; Pigneux, A; Raffoux, E; Rigal-Huguet, F; Stoppa, AM; Thomas, X; Vekhoff, A	1
Avvisati, G; Breccia, M; Carmosino, I; Cimino, G; Iorio, N; Latagliata, R; Lo-Coco, F; Mandelli, F; Minni, A; Petti, MC; Testi, A	1
Alvarez, C; Bolufer, P; Brunet, S; Colomer, D; Díaz-Mediavilla, J; Escoda, L; Esteve, J; González San Miguel, JD; González, M; Martín, G; Rivas, C; Rubio, V; Sánchez Godoy, P; Sanz, MA; Sayas, MJ; Tomás, JF; Tormo, M	1
Barnett, MJ; Bruyere, H; Dalal, BI	1
Couban, S; Greer, W; Hayne, O; Sadek, I; Shawwa, A; Sparavalo, N; Zayed, A	1
Fadilah, SA; Leong, CF; Raja-Zahratul-Azma, RS	1
Chen, FY; Luo, ZG; Ouyang, RR; Wang, HR; Zhong, L	1
Ahmed, Z; Byrd, RP; Mehta, JB; Raval, A; Roy, TM; Shaikh, MA	1
Wang, J; Yang, C	1
Cancelas, JA; Cerveró, C; García-Laraña, J; López, J; Navarro, JL; Odriozola, J; Pérez-Oteyza, J; Sánchez-Sousa, A; Sastre, JL	1
Endo, K; Ichinohasama, R; Imaizumi, M; Inoue, S; Koizumi, Y; Sato, A; Sawai, T; Suwabe, N; Suzuki, H; Yoshinari, M	1
Bassini, A; Celeghini, C; Gibellini, D; Manfroi, S; Ottaviani, E; Pagliarini, C; Tosi, P; Tura, S; Visani, G; Zauli, G	1
Anzai, S; Fujimaki, K; Fujisawa, S; Fukawa, H; Hattori, M; Motomura, S; Okubo, T	1
An, B; Dou, QP; Will, PL	1
Lin, B; Wu, D; Xia, X	1
Scheinberg, DA	1
Arima, N; Hidaka, S; Matsumoto, T; Matsushita, K; Ohtsubo, H; Tanaka, H	1
Akiyama, Y; Bessho, R; Furusho, K; Kataoka, A; Kubota, M; Lin, YW; Okuda, A; Usami, I; Wakazono, Y	1
Bickers, J; Files, JC; Fishleder, A; Foucar, K; Head, D; Kopecky, KJ; Miller, M; Montiel, M; Ryan, D; Weick, J	1
Bleiberg, I; Fabian, I; Kashman, Y; Lishner, M; Rudi, A; Shur, I	1
Amadori, S; Avvisati, G; Cedrone, M; Cimino, G; Mancini, F; Mandelli, F; Moleti, ML; Testi, AM; Todisco, E	1
Han, R; Li, L; Xia, L	1
Horber, DH; Schott, H; Schwendener, RA	1
Gunning, K; Harman, K; Mahendra, P; Marcus, RE; Phillips, M	1
Bauduer, F; Cymbalista, F; Delmer, A; Fenaux, P; Marie, JP; Martin, A; Rio, B; Zittoun, R	1
Archim-Baud, E; Castaigne, S; Chastang, C; Chomienne, C; Degos, L; Fenaux, P; Fey, M; Link, H; Löwenberg, B; Sanz, M	1
Barnett, MJ; Bredeson, CN; Dalal, BI; Horsman, DE; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Spinelli, JJ; Tezcan, H	1
Fenaux, P	1
Asou, N; Kanamaru, A; Kobayashi, T; Kuriyama, K; Murakami, H; Ohmoto, E; Sakamaki, H; Takemoto, Y; Tanimoto, M; Tsubaki, K	1
Cenacchi, A; Gamberi, B; Manfroi, S; Ottaviani, E; Tosi, P; Tura, S; Visani, G	1
Barbui, T; Bassan, R; Battista, R; Buelli, M; d'Emilio, A; Dini, E; Montaldi, A; Rambaldi, A; Tremul, L; Viero, P	1
Caron, PC; Finn, RD; Jurcic, JG; Larson, SM; Maslak, P; Miller, WH; Scheinberg, DA; Warrell, RP; Yao, TJ	1
Case, LD; Gregory, BW; Kucera, GL; Powell, BL; Wang, LM	1
Igarashi, Y; Ishiyama, K; Kumagai, H; Sasaki, H; Satoh, S; Yahagi, A	1
Gadner, H; Krieger, O; Schmitt, K; Schwarz, R; Tulzer, G; Zoubek, A	1
Chastang, C; Chomienne, C; Degos, L; Fenaux, P	1
Chen, A; Hellinger, N; Licht, JD; Scher, W; Waxman, S; Wu, Y	1
Bartimole, TM; Grant, S; Jarvis, WD; Joe, VC; Nelms, PA; Turner, AJ	1
Bessho, R; Hirota, H; Kawai, M; Kubota, M; Kuwakado, K; Lin, YW; Matsubara, K; Nishikomori, R; Okuda, A; Wakazono, Y	1
Chen, SJ; Gu, YZ; Huang, LA; Lu, JX; Ouyang, RR; Sun, GL; Wang, ZY	1
Corey, SJ; Gollin, SM; Locker, J; Oliveri, DR; Penchansky, L; Redner, RL; Shekhter-Levin, S	1
Haase, D; Hehlmann, R; Hild, F; Lengfelder, E; Simon, M	1
Ikeda, Y; Iki, S; Ohbayashi, Y; Urabe, A; Yoshinaga, K	1
Batlle, J; López Fernández, MF; Rodríguez Gómez, M	1
Daniel, LW; Pauig, SB; Small, GW; Strum, JC	1
Eardley, AM; Heller, G; Warrell, RP	1
Haas, OA; Kapiotis, S; Knöbl, P; Korninger, L; Kyrle, PA; Laczika, K; Mitterbauer, G; Oehler, L; Pont, J; Schwarzinger, I	1
Gassmann, W; Glass, B; Haferlach, T; Löffler, H	1
Han, R; Jing, YK	1
Aricò, M; Bossi, G; Comelli, A; Egeler, RM; Piombo, M; Raiteri, E	1
Becher, R; Fonatsch, C; Gassmann, W; Haase, D; Haferlach, T; Jürgensen, C; Löffler, H; Ludwig, WD; Noak, J; Thiel, E	1
Arborio, M; De Revel, T; Desangles, F; Flandrin, G; Vilain, E	1
Garcés-Eisele, J; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ	1
Gadner, H; Koller, E; Krieger, O; Lutz, D; Schmitt, K; Schwarz, R; Tulzer, G; Zoubek, A	1
Catalano, L; Frigeri, F; Luciano, L; Notaro, R; Pane, F; Rotoli, B; Salvatore, F; Santoro, LE; Selleri, C	1
Hoffman, MA; Kleiner, GJ; Wiernik, PH	1
Bear, HD; Chelliah, J; Freemerman, AJ; Grant, S; Jarvis, WD; Mikkelsen, R; Rao, AS	1
Estey, EH; Freireich, EJ; Ghaddar, HM; Kantarjian, HM; Keating, MJ; Pierce, S	1
Birrer, MJ; Chelliah, J; Freemerman, AJ; Grant, S; Jarvis, WD; Martin, HA; Szabo, E; Turner, AJ	1
Ma, L; Qiao, Z; Wang, C; Yang, L; Zhang, H; Zhang, J	1
Asou, H; Awaya, N; Ikeda, Y; Kamada, N; Kawai, Y; Kizaki, M; Matsushita, H; Muto, A; Takayama, N; Ueno, H	1
Cao, DC; Higashigawa, M; Hori, H; Ido, M; Kawasaki, H; Komada, Y; Kuwabara, H; Ohkubo, T; Sakurai, M	1
Escudier, SM; Estey, EH; Kantarjian, HM	1
Kakihara, T; Kataoka, S; Kishi, K; Okada, R; Tanaka, A; Uchiyama, M; Watanabe, A; Yamamoto, K	1
Gonzalez-Gonzalez, A; Pinilla, J; Requena, A; Velasco, JG	1
Chomienne, C; Degos, L; Fenaux, P	1
Chan, CH; Chan, LC; Chan, TK; Chim, CS; Chu, YC; Kwong, YL; Liang, R; Wong, KF	1
Appelbaum, FR; Chen, IM; Godwin, J; Head, DR; Kopecky, KJ; Leith, CP; McConnell, T; Slovak, ML; Willman, CL	1
Battistini, E; Dini, G; Gandolfo, A; Garaventa, A; Kotitsa, Z; Morando, A; Rossi, GA; Savioli, C	1
Arthur, DC; Bigner, S; Bloomfield, CD; Carroll, AJ; Davey, FR; Lawrence, D; Mayer, RJ; Mrózek, K; Pettenati, MJ; Rao, KW; Schiffer, CA; Slack, JL; Tantravahi, R	1
Ohnishi, K; Ohno, R; Shinjyo, K; Takeshita, A; Tobita, T; Yanagi, M	1
Hiraoka, A; Karasuno, T; Kitamura, K; Miyawaki, S; Naoe, T; Ohnishi, K; Ohno, R; Takeshita, A; Takeuchi, M; Tobita, T; Ueda, R; Yanagi, M	1
Avvisati, G; Capria, S; Diverio, D; Lo Coco, F; Mandelli, F; Meloni, G; Petti, MC; Vignetti, M	1
Harano, H; Kanamori, H; Matsuzaki, M; Mohri, H; Ogawa, K; Okubo, C; Okubo, T; Otsuka, M; Sasaki, S; Taguchi, J	1
Maiolino, A; Nucci, M; Pulcheri, W; Spector, N	1
Ahn, HS; Choi, HS; Rhu, KH; Shin, HY; Sung, KW; Yoo, ES	1
Andersen, JW; Appelbaum, FR; Bloomfield, CD; Feusner, JH; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Wiernik, PH; Willman, C	1
Babić, D; Bila, JS; Colović, MD; Elezović, I; Janković, GM; Novak, A; Vidović, A	1
Mandelli, F	1
Honma, Y; Kanatani, Y; Matsuda, A; Niitsu, N; Shuto, S; Umeda, M; Yamamoto-Yamaguchi, Y	1
Asami, K; Eguchi, H; Fujimoto, T; Gushiken, T; Hirota, T; Hyakuna, N; Imaizumi, M; Kamitamari, A; Katano, N; Kawakami, K; Koizumi, S; Komatu, K; Miyake, M; Mugishima, H; Nakadate, N; Nishikawa, K; Shirahata, A; Takitani, K; Tsurasawa, M; Yanase, T	1
Adachi, K; Akiyama, H; Asou, N; Emi, N; Hiraoka, A; Kageyama, S; Kanamaru, A; Kitano, K; Kuriyama, K; Matsuda, S; Miyawaki, S; Nishikawa, K; Oh, H; Ohno, R; Ohtake, S; Omoto, E; Saito, K; Suzushima, H; Takahashi, M; Takeyama, K; Tamura, J; Tsubaki, K; Yamada, O	1
Amarante-Mendes, GP; Bhalla, K; Green, DR; Huang, Y; Liu, L; Naekyung Kim, C; Perkins, CL	1
Qiau, Z; Wang, C; Yang, L	1
Carrera, I; Ding, W; Gallagher, RE; Grills, G; Li, YP; Nobile, LM; Paietta, E; Tallman, MS; Wiernik, PH	1
Archimbaud, E; Fiere, D; Thomas, X	1
Caillot, D; Chastang, C; Chomienne, C; Condé, E; De Botton, S; de la Serna, J; Degos, L; Dombret, H; Fenaux, P; Gardembas, M; Gardin, C; Geiser, K; Guerci, A; Lefrere, F; Makhoul, DC; Miguel, JS; Reman, O; Sanz, M; Stamatoulas, A; Zittoun, R	1
Han, J; Sun, G; Zhao, J	1
Biondi, A; Coppi, MR; Liso, V; Mestice, A; Mininni, D; Palumbo, G; Pogliani, EM; Rossi, V; Specchia, G; Teruzzi, E	1
Bernasconi, C; Castagnola, C; Corso, A; Dabusti, M; Lazzarino, M; Lunghi, M; Tajana, M; Zappasodi, P	1
Chelstrom, LM; Ek, O; Evans, WE; Gunther, R; Messinger, Y; Myers, DE; Perentesis, JP; Schneider, E; Shao, Y; Uckun, FM; Waurzyniak, B; Yanishevski, Y	1
Harada, M; Kibata, M; Ohno, R; Omoto, E; Shudo, K; Takahashi, K; Takeuchi, M; Ueda, R; Yano, T	1
Advani, SH; Bapna, A; Gladstone, B; Gopal, R; Kadam, P; Nair, CN; Nair, R; Parekh, PM; Saikia, TK	1
Janckila, A; Varghese, L; Yam, LT	1
Chillón, C; García, JL; González, M; Gutiérrez, NC; Hernández, JM; Muntión, S	1
Camera, A; Catalano, L; Picardi, M; Rotoli, B; Selleri, C	1
Amess, J; Carter, M; Howe, K; Lister, TA; Rohatiner, AZ; Slater, S	1
Mollee, PN; Rodwell, R; Taylor, D; Taylor, KM; Williams, B	1
Bernardo, M; Conduto, A; Costa, I; Cruz, E; Fernandes, JP; Ferreira, G; Gonçalves, AJ; Gouveia, J; Monteiro, A; Nunes, O; Ribeiro, P; Rodrigues, AS; Sousa, AB; Sousa, M; Veiga, J	1
Demidova, IA; Galstian, GM; Isaev, VG; Kliasova, GA; Ol'shanskaia, IuV; Parovichnikova, EN; Pivnik, AV; Savchenko, VG; Tikhonova, LIu; Tiurina, NG	1
Bishop, JF; Bradstock, KF; Cobcroft, R; Eliadis, P; Enno, A; Gill, D; Herrmann, RP; Juneja, S; Lowenthal, RM; Manoharan, A; Matthews, JP; Page, FJ; Rooney, KF; Rosenfeld, D; Seldon, M; Taylor, KM; Wolf, MM; Young, GA	1
Avvisati, G; Biondi, A; Carlo-Stella, C; Diverio, D; Lo Coco, F; Mandelli, F; Martino, B; Meloni, G; Petti, MC; Pogliani, EM; Rossi, G; Selleri, C; Specchia, G	1
Alaejos, I; Arbeteta, J; Balanzategui, A; Chillón, MC; García-Sanz, R; González, D; González, M; Hernández, JM; López-Pérez, R; Mateos, MV; Orfao, A; Rayón, C; San Miguel, J	1
Iwata, N; Kawahigashi, N; Kobayashi, Y; Maeda, A; Saito, T; Takaue, Y; Takenaka, T; Tanosaki, R; Tobinai, K; Togitani, K	1
Andersen, JW; Appelbaum, FR; Feusner, JH; François, C; Larson, RS; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Wiernik, PH	1
Andersen, JW; Bloomfield, CD; Gallagher, RE; Li, YP; Slack, JL; Tallman, MS; Viswanatha, DS; Willman, CL	1
Minamikawa, K; Nakase, K; Shiku, H; Wakita, Y; Yamaguchi, T	1
Haas, OA; Jaeger, U; Knöbl, P; Laczika, K; Lechner, K; Mitterbauer, G; Thalhammer-Scherrer, R; Weltermann, A	1
Berthou, C; Buzyn, A; Cahn, JY; Chomienne, C; Cordonnier, C; de Revel, T; Degos, L; Dombret, H; Fegueux, N; Fenaux, P; Gardin, C; Gratecos, N; Guerci, A; Huguet, F; Kotoucek, P; Maloisel, F; Naccache, P; Pigneux, A; Reman, O; Sadoun, A; Stamatoullas, A; Thomas, X; Travade, P; Vekhoff, A; Vilque, JP	1
Boros, B; Egyed, M; Földi, J; Páldi-Haris, P; Rumi, G	1
Avvisati, G; Diverio, D; Lo Coco, F; Mandelli, F	1
Aul, C; Beelen, D; Büchner, T; Fonatsch, C; Gassmann, W; Haase, D; Haferlach, T; Hehlmann, R; Heinecke, A; Heyll, A; Hiddemann, W; Hochhaus, A; Lengfelder, E; Löffler, H; Ludwig, WD; Reichert, A; Sauerland, MC; Saussele, S; Schoch, C; Seifarth, W; Staib, P; Wörmann, B	1
Avvisati, G; Barbui, T; Bernasconi, C; Bolufer, P; Colomer, D; Díaz-Mediavilla, J; Esteve, J; Ferrara, F; Fioritoni, G; González, JD; Gonzalez, M; Liso, V; Lo Coco, F; Mandelli, F; Martín, G; Petti, MC; Rayón, C; Ribera, JM; Rodeghiero, F; Sanz, MA	1
Adachi, K; Akiyama, H; Asou, N; Hiraoka, A; Kageyama, S; Kanamaru, A; Ohno, R; Omoto, E; Tamura, J	1
Catani, L; Grafone, T; Gugliotta, L; Isidori, A; Martinelli, G; Nocentini, F; Ottaviani, E; Pastano, R; Piccaluga, P; Testoni, N; Tosi, P; Tura, S; Vianelli, N; Visani, G	1
Avigdor, A; Ben-Bassat, I; Bercowicz, M; Berkenstat, H; Levi, I; Perel, A; Raanani, P; Segal, E	1
Abhyankar, D; Advani, S; Kapoor, B; Menon, H; Nair, R	1
Bordessoule, D; Castaigne, S; Chevret, S; Chomienne, C; Cony Makhoul , P; De Botton , S; Deconinck, E; Degos, L; Desablens, B; Dombret, H; Fegueux, N; Fenaux, P; Fey, M; Gardin, C; Geiser, K; Guerci, A; Hess, U; Huguet, F; Link, H; Maloisel, F; Preudhomme, C; Rayon, C; San Miguel , J; Sanz, M; Solary, E; Sotto, JJ; Stamatoullas, A; Thomas, X; Travade, P	1
Powell, BL	1
Honma, Y; Ishii, Y; Matsuda, A; Niitsu, N	1
Cabrera, ME; Ducach, G; Etcheverry, R; Puga, BL; Toledo, H; Undurraga, MS; Vacarezza, R	1
Cuneo, A; Liso, V; Mestice, A; Pannunzio, A; Rocchi, M; Specchia, G; Storlazzi, CT; Surace, C	1
Albertioni, F; Eriksson, S; Löfgren, C; Månsson, E; Paul, A; Paul, C; Ullberg, K	1
Estey, EH	1
Basu, S; Chachlani, N; Kalk, E; Rose, P	1
Debén, G; Díaz-Mediavilla, J; Esteve, J; González-San Miguel, JD; Martin, G; Rayón, C; Sanz, MA; Tormo, M	1
Enomoto, S; Ishida, Y; Itoh, S; Kuriya, S; Murai, K; Numaoka, H; Ono, Y; Sugawara, T; Utsugisawa, T	1
Alimena, G; Breccia, M; Cimino, G; De Carolis, S; Lo Coco, F; Mandelli, F	1
Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T	1
Dabadghao, S; Melinkeri, SR; Mishra, SK	1
Cayado, N; Gramatges, A; Hernández, P; Losada, R; Machín, S; Martinez, G	1
Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T	1
Kafka, M; Kapelushnik, J; Moser, A; Yermiahu, T	1
Mitchell, DC; Win, N	1
Ashihara, E; Fujita, N; Gotoh, H; Inaba, T; Itoh, K; Murakami, S; Nishio, A; Ohkawa, K; Oku, N; Shimazaki, C	1
Archimbaud, E; Castaigne, S; Dombret, H; Duarte, M; Fenaux, P; Guerci, A; Lamy, T; Maloisel, F; Morel, P; Tilly, H	1
Gewirtz, DA; Grant, S; Jarvis, WD; Lin, PS; Pettit, GR; Swerdlow, PS; Traylor, RS; Turner, AJ; Wallace, HJ	1
Goldenberg, NA; Kolla, SS; Studzinski, GP; Xu, HM	1
Bhalla, K; Grant, S; Holladay, C; Huang, Y; Hughes, M; Ibrado, AM; Mahoney, ME; Tang, C; Tourkina, E	1
Belloc, F; Bernard, P; Boisseau, MR; Dumain, P; Lacombe, F; Lopez, F; Puntous, M; Reiffers, J	1
Abe, Y; Goto, T; Katsuno, M; Miyoshi, T; Muta, K; Nishimura, J; Sadamura, S; Taguchi, F; Takatsuki, H; Umemura, T	1
Akiyoshi, T; Hisano, S; Ishibashi, M; Kimura, N; Morioka, E; Okumura, M; Suzumiya, J; Uchida, T	1
Elliott, S; Marlton, P; Meagher, D; Rodwell, R; Taylor, D; Taylor, K; Timms, P; White, S; Wiley, J; Wright, S	1
Benedetti-Panici, P; De Vincenzo, R; Iovino, MS; Leone, G; Macrì, E; Menichella, G; Piantelli, M; Pierelli, L; Scambia, G; Teofili, L	1
Coppetelli, U; del Poeta, G; Papa, G; Stasi, R; Tribalto, M; Venditti, A; Zaccari, G	1
Cuddy, DP; de Valeriola, DL; Egorin, MJ; Forrest, A; Ross, DD	1
Alegre, A; Algora, M; García Plaza, I; Llanos, ML; Lozano, M; Padilla, B; Peñalver, MA; Pérez-Pons, C	1
Mejer, J	1
Bordessoule, D; Castaigne, S; Colombat, P; Fenaux, P; Guy, H; Le Gall, E; Leblay, R; Leverger, G; Tertian, G; Tilly, H	1
Costello, C; McCarthy, D; Mir, N; Nadir, F; Rule, S; Samson, D; Taylor, J	1
Datta, R; Kharbanda, S; Kufe, D	1
Bouffard, DY; Marie, JP; Marquet, J; Momparler, LF; Momparler, RL; Zittoun, J; Zittoun, R	1
Antony, J; Bergin, M; Menser, MA; Procopis, PG; Shaw, PJ; Stevens, MM	1
Degos, L	2
Kirtley, DW; Thomas, E; Votaw, ML	1
Chen, SR; Cuddy, DP; Ross, DD	1
Aotsuka, N; Asai, T; Endoh, N; Hirasawa, A; Hiruma, K; Ishii, H; Morio, S; Oh, H; Wakita, H; Yoshida, S	1
del Potro Gómez, E; Díaz Mediavilla, J; Díaz Morfa, M; Espinos Pérez, D; López Martín, JC; Martínez Martínez, R	1
Akiyama, Y; Kiriyama, Y; Kito, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A	2
Akiyama, Y; Kitoh, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A; Tsuruta, S	1
Benstead, TJ; Hayne, OA; McCormick, CW; Nevill, TJ	1
Mejer, J; Mortensen, BT	1
de Waal, FC; Huijgens, PC; Jalink, W; Langenhuijsen, MM; Ossenkoppele, GJ; vd Berg, TA; Wijermans, PW	1
Chubachi, A; Endo, Y; Miura, AB; Nishimura, S	1
Akahoshi, Y; Asou, N; Fujimoto, K; Fukuda, S; Ishimaru, S; Kawano, F; Murai, C; Sawatari, T; Taen, A; Takatsuki, K	1
Akiyama, Y; Kiriyama, Y; Kitoh, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A	2
Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y	1
Annino, L; Avvisati, G; Carella, AM; Caronia, F; Carotenuto, M; Giona, F; Mandelli, F; Meloni, G; Petti, MC; Testi, AM	1
Horiuchi, H; Kobayashi, Y; Kondo, M; Nishimura, S; Ozawa, M; Shigeta, M; Shirakata, S; Tashiro, K	1
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Itami, S; Mizunuma, N; Mukaiyama, T; Ogawa, M; Tabata, M	1
Hashimoto, M; Hirose, S; Horie, S; Ishiyama, T; Saito, K; Seekikawa, I; Sugimoto, M; Wakabayashi, Y	1
Alvarez, A; del Potro, E; Díaz Mediavilla, J; Díaz Morfa, M; Guerra, JL; Krsnik, I; Llorente, L; López, JC; Martínez, R; Villegas, A	1
David, JC; Maniey, D; Marquet, J; Zittoun, J; Zittoun, R	1
Bologna, S; Link, MP; Miller, L; Parker, BR	1
Arlin, ZA; Feldman, EJ	1
Imoto, S; Ito, M; Nakagawa, T; Okamura, A; Saito, S; Taomoto, K; Yamada, H	1
Mandelli, F; Petti, MC	1
Clarkson, BD; Cunningham, I; Gee, TS; Kempin, SJ; Naval, AN; Reich, LM	1
Chou, TC; Fanucchi, MP; Kong, XB	1
Pályi, I	1
Cohen, A; Estrov, Z; Freedman, MH; Gelfand, EW	1

Reviews

35 review(s) available for cytarabine and Leukemia, Promyelocytic, Acute

Article	Year
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future. Minerva medica, 2020, Volume: 111, Issue:5 Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Calicheamicins; Chlorides; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Approval; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Mice; Middle Aged; Multicenter Studies as Topic; Recurrence; Sialic Acid Binding Ig-like Lectin 3; Tretinoin	2020
Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review. Medicine, 2020, Oct-23, Volume: 99, Issue:43 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Asian People; Consolidation Chemotherapy; Cytarabine; Decitabine; Drug Therapy, Combination; Female; Hospitalization; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Retinoic Acid Receptor alpha; STAT5 Transcription Factor; Treatment Outcome; Tretinoin	2020
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach. Cancer, 2021, 04-15, Volume: 127, Issue:8 Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Bridged Bicyclo Compounds, Heterocyclic; Cladribine; Core Binding Factors; Cytarabine; Daunorubicin; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mutation; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm, Residual; Sulfonamides; Survival Rate; Translational Research, Biomedical; Tretinoin; Vidarabine	2021
Development of a curative treatment within the AML-BFM studies. Klinische Padiatrie, 2013, Volume: 225 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Thioguanine; Vincristine	2013
[Acute promyelocytic leukemia presenting with central nervous system involvement at initial diagnosis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2013, Volume: 54, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Central Nervous System Neoplasms; Cytarabine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Invasiveness; Treatment Outcome; Tretinoin	2013
[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Discovery; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Mutation; Recurrence; Tretinoin; Vincristine	2014
Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care. Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1 Topics: Adult; Age Factors; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Blood Coagulation Factors; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Hydroxyurea; Idarubicin; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Oxides; Platelet Transfusion; Practice Guidelines as Topic; Remission Induction; Risk Assessment; Thioguanine; Treatment Outcome; Tretinoin	2014
The expanding role of arsenic in acute promyelocytic leukemia. Seminars in hematology, 2008, Volume: 45, Issue:3 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Oxides; Treatment Outcome; Tretinoin	2008
Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. Puerto Rico health sciences journal, 2009, Volume: 28, Issue:2 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Drug Synergism; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Monosomy; Neoplasms, Second Primary; Translocation, Genetic; Tretinoin	2009
[Standard therapies for acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10 Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenites; Cytarabine; Daunorubicin; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Remission Induction	2009
[Acute lower limb ischemia revealing acute leukemia. Case report and review of the literature]. Journal des maladies vasculaires, 2010, Volume: 35, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cytarabine; Daunorubicin; Emergencies; Femoral Artery; Humans; Ischemia; Leg; Leukemia, Promyelocytic, Acute; Leukostasis; Male; Popliteal Artery; Remission Induction; Thrombectomy; Tretinoin	2010
Is cytarabine required in the treatment of acute promyelocytic leukemia? Current hematologic malignancy reports, 2006, Volume: 1, Issue:2 Topics: Adult; Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome; Tretinoin	2006
Modern approaches to treating acute promyelocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Feb-10, Volume: 29, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Oxides; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Tretinoin	2011
Advances in therapies for acute promyelocytic leukemia. Cancer science, 2011, Volume: 102, Issue:11 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Differentiation; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Multicenter Studies as Topic; Oncogene Proteins, Fusion; Oxides; Risk; Salvage Therapy; Tretinoin	2011
Current treatment strategy of acute promyelocytic leukemia. Frontiers of medicine, 2011, Volume: 5, Issue:4 Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Oxides; Prognosis; Secondary Prevention; Survival Rate; Tretinoin	2011
Central nervous system relapse in acute promyelocytic leukemia. American journal of hematology, 2002, Volume: 71, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Methotrexate; Tretinoin	2002
[Expanding possibilities, strategic considerations, and novel methods in the diagnosis and chemotherapy of adult acute myeloid leukemia]. Orvosi hetilap, 2003, Sep-07, Volume: 144, Issue:36 Topics: Adult; Anthracyclines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Oligonucleotide Array Sequence Analysis; Oxides; Palliative Care; Prognosis; Remission Induction; Tretinoin	2003
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Bone marrow transplantation, 2003, Volume: 32, Issue:12 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous	2003
[Recent progress in diagnosis of and therapy for patients with leukemia]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Mar-10, Volume: 93, Issue:3 Topics: Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Cytarabine; Drug Monitoring; Fusion Proteins, bcr-abl; Gene Targeting; Genes, Wilms Tumor; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplasm, Residual; Oncogene Proteins, Fusion; Pharmacogenetics; Piperazines; Pyrimidines; Recombinant Fusion Proteins; Therapeutic Equivalency; Tretinoin	2004
[Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Liver Transplantation; Living Donors; Ornithine Carbamoyltransferase Deficiency Disease; Remission Induction; Tacrolimus; Tretinoin	2004
Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature. Clinical advances in hematology & oncology : H&O, 2006, Volume: 4, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Treatment Outcome	2006
Adult leukaemia in 1995: new directions. Lancet (London, England), 1995, Aug-19, Volume: 346, Issue:8973 Topics: Adult; Aged; Bone Marrow Transplantation; Child; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic; Tretinoin	1995
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group. Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Differentiation; China; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Europe; Humans; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Middle Aged; Mitoxantrone; New York; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin	1995
Acute promyelocytic leukemia and pregnancy. A case report. Cancer, 1995, Dec-01, Volume: 76, Issue:11 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Fetal Death; Humans; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Prenatal Care; Remission Induction; Tretinoin	1995
Acute promyelocytic leukemia: biology and treatment. Seminars in oncology, 1997, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Neoplasm, Residual; Recurrence; Translocation, Genetic; Tretinoin	1997
New strategies for the treatment of acute promyelocytic leukaemia. Journal of internal medicine. Supplement, 1997, Volume: 740 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Remission Induction; Treatment Outcome; Tretinoin	1997
Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80. Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Benzoates; Biomarkers, Tumor; Cheilitis; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Pilot Projects; Recurrence; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin; Tumor Cells, Cultured	1998
Acute promyelocytic leukemia. New methods in diagnosis and treatment. The Journal of the Kentucky Medical Association, 1999, Volume: 97, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Male; Translocation, Genetic; Tretinoin	1999
Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia. Haematologica, 1999, Volume: 84 Suppl EHA-4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Forecasting; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oncogene Proteins, Fusion; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Translocation, Genetic; Treatment Outcome; Tretinoin	1999
Acute progranulocytic leukemia. Current opinion in oncology, 2001, Volume: 13, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Clinical Trials as Topic; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Neoplasm, Residual; Oxides; Prognosis; Salvage Therapy; Survival Analysis; Tretinoin	2001
Therapeutic options for acute myelogenous leukemia. Cancer, 2001, Sep-01, Volume: 92, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Colony-Stimulating Factors; Cytarabine; Cytogenetics; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Prognosis; Topotecan; Vidarabine	2001
AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Haematologica, 2002, Volume: 87, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Disseminated Intravascular Coagulation; Female; Gestational Age; Humans; Idarubicin; Infant, Newborn; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic; Remission Induction; Risk; Tretinoin	2002
Differentiating agents in the treatment of leukemia. Leukemia research, 1990, Volume: 14, Issue:8 Topics: Cell Differentiation; Cytarabine; Humans; Interferon Type I; Leukemia; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes; Tretinoin	1990
Differentiating agents in the treatment of leukemia and myelodysplastic syndromes. Leukemia research, 1990, Volume: 14, Issue:8 Topics: Cell Differentiation; Cell Division; Cytarabine; Humans; Interferon Type I; Leukemia; Leukemia, Hairy Cell; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes; Tretinoin	1990
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone; Remission Induction	1989

Trials

75 trial(s) available for cytarabine and Leukemia, Promyelocytic, Acute

Article	Year
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 11-01, Volume: 41, Issue:31 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; East Asian People; Homoharringtonine; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin	2023
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Sep-10, Volume: 35, Issue:26 Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Female; Historically Controlled Study; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Oxides; Young Adult	2017
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines. European journal of haematology, 2018, Volume: 100, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Consolidation Chemotherapy; Cytarabine; Cytogenetic Analysis; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm, Residual; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin; Young Adult	2018
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial. BMC cancer, 2018, 04-03, Volume: 18, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Biomarkers; Case-Control Studies; Child; Child, Preschool; Consolidation Chemotherapy; Cytarabine; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin	2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance). Pediatric blood & cancer, 2019, Volume: 66, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Prognosis; Survival Rate; Tretinoin	2019
Lung resistance-related protein (LRP) predicts favorable therapeutic outcome in Acute Myeloid Leukemia. Scientific reports, 2019, 01-23, Volume: 9, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bone Marrow; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Vault Ribonucleoprotein Particles	2019
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia. Blood, 2013, Apr-18, Volume: 121, Issue:16 Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxides; Remission Induction; Transcription, Genetic; Transplantation, Autologous; Young Adult	2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients. American journal of hematology, 2013, Volume: 88, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Risk Factors; Treatment Outcome; Tretinoin	2013
Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts. Cancer science, 2014, Volume: 105, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cytarabine; Disease-Free Survival; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Tretinoin; Young Adult	2014
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. British journal of haematology, 2014, Volume: 165, Issue:4 Topics: Adult; Aged; Aminoglycosides; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dogs; Female; Gemtuzumab; Humans; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Oncogene Proteins, Fusion; Oxides; Platelet Count; Remission Induction; Risk; Treatment Outcome; Tretinoin; Young Adult	2014
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia. Cancer, 2008, Nov-01, Volume: 113, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Prognosis; Remission Induction; Survival Rate	2008
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia, 2009, Volume: 23, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Germany; Humans; Leukemia, Promyelocytic, Acute; Longitudinal Studies; Lymphocyte Count; Middle Aged; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin; Young Adult	2009
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. Pediatric blood & cancer, 2009, Volume: 53, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin	2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and C Blood, 2010, Feb-04, Volume: 115, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Proteins; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Genotype; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Reverse Transcriptase Polymerase Chain Reaction; Thioguanine; Treatment Outcome; Tretinoin; Young Adult	2010
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood, 2010, Mar-04, Volume: 115, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Europe; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Time Factors; Treatment Outcome; Tretinoin	2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-20, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxides; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult	2010
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. British journal of haematology, 2010, Volume: 149, Issue:3 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Recurrence; Survival Analysis; Treatment Outcome; Tretinoin	2010
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood, 2010, Oct-28, Volume: 116, Issue:17 Topics: Adolescent; Adult; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Remission Induction; Tretinoin; Young Adult	2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood, 2010, Nov-11, Volume: 116, Issue:19 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; North America; Oxides; Survival Analysis; Treatment Outcome; Tretinoin; Young Adult	2010
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study. British journal of haematology, 2011, Volume: 152, Issue:1 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Cytarabine; Epidemiologic Methods; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Neoplasm, Residual; Neutropenia; Prognosis; Recurrence; Treatment Outcome; Tretinoin	2011
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Blood, 2010, Dec-16, Volume: 116, Issue:25 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult	2010
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors. British journal of haematology, 2011, Volume: 154, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hemorrhage; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Opportunistic Infections; Prognosis; Remission Induction; Survival Analysis; Tretinoin	2011
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. Blood, 2011, Dec-15, Volume: 118, Issue:25 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cytarabine; Daunorubicin; Disease-Free Survival; Dyspepsia; Female; Follow-Up Studies; Headache; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Tretinoin	2011
The early addition of arsenic trioxide versus high-dose arabinoside is more effective and safe as consolidation chemotherapy for risk-tailored patients with acute promyelocytic leukemia: multicenter experience. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Tretinoin; Young Adult	2012
Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation. Leukemia research, 2012, Volume: 36, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disseminated Intravascular Coagulation; Female; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recombinant Proteins; Thrombomodulin; Tretinoin	2012
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Humans; Idarubicin; Infections; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vomiting	2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 2002, Dec-15, Volume: 100, Issue:13 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Leukemia, Promyelocytic, Acute; Leukocyte Count; Life Tables; Male; Middle Aged; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin	2002
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Apr-15, Volume: 22, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Treatment Outcome; Tretinoin	2004
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica, 2004, Volume: 89, Issue:7 Topics: Abdominal Pain; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Daunorubicin; Diarrhea; Dibenzocycloheptenes; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nausea; Quinolines; Remission Induction	2004
[Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias]. Terapevticheskii arkhiv, 2004, Volume: 76, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Remission Induction; Transcription, Genetic; Tretinoin	2004
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia, 2005, Volume: 19, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Remission Induction; Tretinoin	2005
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. Bone marrow transplantation, 2005, Volume: 36, Issue:1 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Cytarabine; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Salvage Therapy; Transplantation, Autologous	2005
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-20, Volume: 24, Issue:36 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Analysis; Tretinoin	2006
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention. Leukemia, 2007, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Liposomes; Male; Middle Aged; Mitoxantrone; Neoplasm, Residual; Oncogene Proteins, Fusion; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Survival Analysis; Time Factors; Treatment Outcome; Tretinoin	2007
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group. Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Differentiation; China; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Europe; Humans; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Middle Aged; Mitoxantrone; New York; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin	1995
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial. Leukemia, 1994, Volume: 8 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Europe; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Treatment Outcome; Tretinoin	1994
All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood, 1995, Mar-01, Volume: 85, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Immunologic Factors; Japan; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Male; Mercaptopurine; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Syndrome; Treatment Outcome; Tretinoin	1995
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hematopoiesis; Humans; Idarubicin; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocyte Count; Leukocytosis; Male; Middle Aged; Neutrophils; Platelet Count; Premedication; Remission Induction; Salvage Therapy; Treatment Outcome; Tretinoin	1994
Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia. Leukemia, 1995, Volume: 9, Issue:2 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Cytoplasmic Granules; Disease-Free Survival; Disseminated Intravascular Coagulation; Doxorubicin; Female; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Prospective Studies; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome	1995
Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group. Lancet (London, England), 1994, Apr-23, Volume: 343, Issue:8904 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Tretinoin	1994
Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience. Chinese medical journal, 1993, Volume: 106, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Harringtonines; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prednisone; Remission Induction; Tretinoin; Vincristine	1993
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia. Leukemia, 1994, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Daunorubicin; Drug Therapy; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Time Factors; Tretinoin	1994
Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. Leukemia, 1994, Volume: 8, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chromosomes, Human, Pair 15; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Pilot Projects; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Sensitivity and Specificity; Tretinoin	1994
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group. Annals of hematology, 1993, Volume: 66, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cytarabine; Daunorubicin; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Thioguanine	1993
Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Life Tables; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine	1996
Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers. Leukemia & lymphoma, 1996, Volume: 22, Issue:3-4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Division; Child; Child, Preschool; Cytarabine; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunophenotyping; Infant; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thymidine; Tritium	1996
Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6 Topics: Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cohort Studies; Cytarabine; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Germinoma; Hemorrhage; Humans; Idarubicin; Incidence; Infarction; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Melanoma; Middle Aged; Myocardial Infarction; Neoplasms, Multiple Primary; Remission Induction; Retrospective Studies; Spleen; Thrombosis; Treatment Outcome; Tretinoin	1996
All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL). Hematological oncology, 1996, Volume: 14, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Tretinoin	1996
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 1997, May-01, Volume: 89, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Double-Blind Method; Drug Resistance, Multiple; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recombinant Proteins	1997
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood, 1997, Aug-01, Volume: 90, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Differentiation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Pain; Prospective Studies; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor gamma; Retinoids; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin	1997
Clinical trial of low dose cytosine arabinoside in the treatment of acute promyelocytic leukemia. Journal of Korean medical science, 1997, Volume: 12, Issue:4 Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Promyelocytic, Acute; Male	1997
All-trans-retinoic acid in acute promyelocytic leukemia. The New England journal of medicine, 1997, Oct-09, Volume: 337, Issue:15 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Failure; Tretinoin	1997
Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Medical oncology (Northwood, London, England), 1997, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin	1997
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:11 Topics: Aclarubicin; Administration, Oral; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Prednisolone; Tretinoin; Vincristine	1997
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood, 1998, Aug-15, Volume: 92, Issue:4 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Point Mutation; Remission Induction; Tretinoin; Tumor Cells, Cultured	1998
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood, 1998, Oct-15, Volume: 92, Issue:8 Topics: Acute Kidney Injury; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Humans; Incidence; Leukemia, Promyelocytic, Acute; Leukocyte Count; Life Tables; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Proportional Hazards Models; Remission Induction; Respiration Disorders; Survival Rate; Syndrome; Treatment Outcome; Tretinoin	1998
Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80. Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Benzoates; Biomarkers, Tumor; Cheilitis; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Pilot Projects; Recurrence; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin; Tumor Cells, Cultured	1998
Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone. American journal of hematology, 1999, Volume: 60, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Cytarabine; Daunorubicin; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Tretinoin; Weight Gain	1999
Short-term intensive consolidation therapy after all-trans retinoic acid in acute promyelocytic leukemia. American journal of clinical oncology, 1999, Volume: 22, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prospective Studies; Remission Induction; Survival Analysis; Tretinoin	1999
[Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study]. Terapevticheskii arkhiv, 1999, Volume: 71, Issue:7 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Time Factors; Treatment Outcome; Tretinoin	1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG). Leukemia & lymphoma, 1999, Volume: 34, Issue:5-6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Rate	1999
Therapy of molecular relapse in acute promyelocytic leukemia. Blood, 1999, Oct-01, Volume: 94, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Follow-Up Studies; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Recurrence; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Salvage Therapy; Survival Analysis; Time Factors; Tretinoin	1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood, 2000, Jan-01, Volume: 95, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Female; Fever; Glucocorticoids; Humans; Incidence; Infant; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Remission Induction; Respiratory Distress Syndrome; Syndrome; Tretinoin; Weight Gain	2000
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood, 2000, Jan-15, Volume: 95, Issue:2 Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Cytarabine; Daunorubicin; Exons; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Prognosis; Protein Isoforms; Remission Induction; Sequence Deletion; Transcription, Genetic; Tretinoin	2000
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia, 2000, Volume: 14, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Cytarabine; DNA Primers; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin	2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 2000, Aug-15, Volume: 96, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Predictive Value of Tests; Recurrence; Risk; Thioguanine; Tretinoin	2000
[Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prognosis; Receptors, Retinoic Acid; Remission Induction; Retinoic Acid Receptor alpha; Tretinoin	2000
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia. European journal of haematology, 2000, Volume: 64, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Remission Induction; Retrospective Studies; Tretinoin	2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. British journal of haematology, 2000, Volume: 111, Issue:3 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 8; Chromosomes, Human, Pair 9; Cohort Studies; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate; Translocation, Genetic; Tretinoin; Trisomy	2000
Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy. Haematologica, 2002, Volume: 87, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cuba; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin	2002
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood, 1992, Nov-01, Volume: 80, Issue:9 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoguazone; Pilot Projects; Time Factors; Treatment Outcome; Tretinoin	1992
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:9 Topics: Adolescent; Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Rate	1991
Idarubicin in acute leukaemia. GIMEMA Group. Bone marrow transplantation, 1989, Volume: 4 Suppl 3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1989
Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA. Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Random Allocation; Remission Induction	1989
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood, 1989, Volume: 73, Issue:5 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nervous System Neoplasms; Prognosis; Remission Induction; Thioguanine	1989

Other Studies

206 other study(ies) available for cytarabine and Leukemia, Promyelocytic, Acute

Article	Year
Acute myeloid leukemia with cup-like blasts and FLT3-ITD and NPM1 mutations mimics features of acute promyelocytic leukemia: a case of durable remission after sorafenib and low-dose cytarabine. Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1 Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; fms-Like Tyrosine Kinase 3; HLA-DR Antigens; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nucleophosmin; Sorafenib	2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia. The Korean journal of internal medicine, 2022, Volume: 37, Issue:4 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Cytarabine; Follow-Up Studies; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Recurrence; Remission Induction; Treatment Outcome; Tretinoin	2022
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Pregnancy; Recurrence; Tretinoin; Young Adult	2020
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome. British journal of haematology, 2018, Volume: 181, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Cell Cycle; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; Genotype; Humans; Immunophenotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin	2018
Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics. Current medical science, 2018, Volume: 38, Issue:1 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone	2018
A rare case with typical acute promyelocytic leukemia morphology associated with isolated isochromosome 17q without RARα rearrangement. Hematology/oncology and stem cell therapy, 2013, Volume: 6, Issue:1 Topics: Antibiotics, Antineoplastic; Bone Marrow; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; In Situ Hybridization, Fluorescence; Isochromosomes; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha	2013
All-trans-retinoic acid-induced scrotal ulcers in a patient with acute promyelocytic leukemia. Cutis, 2013, Volume: 91, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Eruptions; Humans; Leukemia, Promyelocytic, Acute; Male; Scrotum; Skin Ulcer; Tretinoin	2013
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. Hematological oncology, 2014, Volume: 32, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; China; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Dexamethasone; Drug Evaluation; Female; Harringtonines; Homoharringtonine; Humans; Idarubicin; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Oxides; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Tretinoin; Young Adult	2014
A novel acidic serine protease, ASPNJ inhibits proliferation, induces apoptosis and enhances chemo-susceptibility of acute promyelocytic leukemia cell. Leukemia research, 2013, Volume: 37, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cell Survival; Cytarabine; Down-Regulation; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Fibrinolytic Agents; Helminth Proteins; Humans; Leukemia, Promyelocytic, Acute; Oligochaeta; Serine Proteases; Tumor Cells, Cultured	2013
[Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2014, Volume: 186, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Diagnosis, Differential; Dyspnea; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Pleural Effusion; Pulmonary Edema; Thioguanine; Tomography, X-Ray Computed; Tretinoin	2014
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age. Annals of hematology, 2015, Volume: 94, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Interferon-alpha; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Mitoxantrone; Remission Induction; Survival Analysis; Time Factors; Treatment Outcome; Tretinoin	2015
A prospective, observational study of added medium-dose cytosine arabinoside versus As2O3 for elderly patients with acute promyelocytic leukemia. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Polymerase Chain Reaction; Prospective Studies; Survival Rate; Tretinoin	2014
Chemotherapy-free treatment of acute promyelocytic leukemia. Clinical advances in hematology & oncology : H&O, 2015, Volume: 13, Issue:8 Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tretinoin	2015
Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles. Colloids and surfaces. B, Biointerfaces, 2016, May-01, Volume: 141 Topics: Antimetabolites, Antineoplastic; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Cell Survival; Circular Dichroism; Cytarabine; DNA; Dose-Response Relationship, Drug; Ferric Compounds; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Magnetite Nanoparticles; Microscopy, Electron, Transmission; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction	2016
High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group. British journal of haematology, 2016, Volume: 174, Issue:3 Topics: Adolescent; Anthracyclines; Child; Child, Preschool; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Humans; Induction Chemotherapy; Infant; Japan; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Prospective Studies; Survival Rate; Treatment Outcome; Tretinoin	2016
[Clinical features and prognostic analysis of high-risk acute promyelocytic leukemia patients]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2016, May-14, Volume: 37, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Oncogene Proteins, Fusion; Platelet Count; Prognosis; Protein Isoforms; Recurrence; Remission Induction; Retrospective Studies; Survival Rate	2016
Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567-572. Blood, 2016, 12-29, Volume: 128, Issue:26 Topics: Blood Coagulation; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Remission Induction; Tretinoin	2016
Bilateral Retinal Hemorrhages in a Young Man. JAMA ophthalmology, 2017, 04-01, Volume: 135, Issue:4 Topics: Adult; Antimetabolites, Antineoplastic; Blood Cell Count; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Male; Retinal Hemorrhage; Retinal Neoplasms; Tretinoin; Visual Acuity	2017
[Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2008, Volume: 10, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Tretinoin	2008
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood, 2008, Nov-01, Volume: 112, Issue:9 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Oxides; Recurrence	2008
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C. International journal of oncology, 2008, Volume: 33, Issue:4 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Models, Chemical; Propidium; Ribonucleotide Reductases; Stilbenes; Time Factors	2008
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood, 2009, Jun-11, Volume: 113, Issue:24 Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured	2009
Chemotherapy induced esophageal stricture. Pediatric blood & cancer, 2009, Volume: 52, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Esophageal Stenosis; Esophagectomy; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Tretinoin	2009
Curative strategies in acute promyelocytic leukemia. Hematology. American Society of Hematology. Education Program, 2008 Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Cytarabine; Daunorubicin; Disease-Free Survival; Growth Inhibitors; History, 20th Century; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Oxides; Tretinoin	2008
Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols. Pediatric blood & cancer, 2009, Volume: 53, Issue:3 Topics: Adolescent; Anthracyclines; Child; Child, Preschool; Cytarabine; Female; Health Care Costs; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin	2009
Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries. Pediatric blood & cancer, 2009, Volume: 53, Issue:3 Topics: Child; China; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Tretinoin	2009
Central nervous system involvement at the time of presentation in acute promyelocytic leukemia. Pediatric blood & cancer, 2010, Volume: 54, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Mercaptopurine; Methotrexate; Oncogene Proteins, Fusion; Radiotherapy; Sarcoma, Myeloid; Tretinoin	2010
Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid. Leukemia research, 2010, Volume: 34, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus cereus; Bacterial Infections; Brain Abscess; Brain Neoplasms; Cytarabine; Female; Humans; Idarubicin; Injections, Spinal; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Methotrexate; Tretinoin	2010
Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow Cells; Cell Proliferation; Cytarabine; Disease Models, Animal; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Leukocytes; Mice; Naphthyridines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thiazoles	2010
Updates on the treatment of acute promyelocytic leukemia. Clinical advances in hematology & oncology : H&O, 2010, Volume: 8, Issue:2 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cytarabine; Daunorubicin; Hemorrhage; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Tetrahydronaphthalenes; Tretinoin	2010
CNS relapse in acute promyeloctyic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Aug-20, Volume: 28, Issue:24 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Neoplasms; Brain Neoplasms; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cranial Irradiation; Cytarabine; Drug Administration Schedule; Female; fms-Like Tyrosine Kinase 3; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Mutation; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome; Tretinoin; Tumor Suppressor Proteins	2010
Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:1 Topics: Antineoplastic Agents; Cytarabine; Fatal Outcome; Female; Hepatitis B; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Tretinoin; Virus Activation	2010
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population. Annals of hematology, 2011, Volume: 90, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Erythropoietin; Female; Hemoglobins; Humans; Jehovah's Witnesses; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Tretinoin	2011
Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology (Amsterdam, Netherlands), 2010, Volume: 15, Issue:4 Topics: 3' Untranslated Regions; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Survival; Cytarabine; Drug Resistance, Neoplasm; Drug Synergism; Genes, Reporter; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; MicroRNAs; Oligodeoxyribonucleotides, Antisense; Osmolar Concentration; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger; Transfection; Up-Regulation	2010
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association? American journal of hematology, 2010, Volume: 85, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin	2010
The role of standard-dose cytarabine in children with acute promyelocytic leukemia: a single-center experience. Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2 Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Tretinoin	2011
Stochastic acquisition of a stem cell-like state and drug tolerance in leukemia cells stressed by radiation. International journal of hematology, 2011, Volume: 93, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Antimicrobial Cationic Peptides; Cytarabine; Drug Resistance, Neoplasm; Gamma Rays; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred NOD; Neoplastic Stem Cells; Radiation Tolerance; Reactive Oxygen Species; Tretinoin	2011
Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis. Clinical and experimental nephrology, 2011, Volume: 15, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Middle Aged; Mitomycin; Remission Induction; Renal Dialysis; Tretinoin	2011
Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia. Leukemia research, 2011, Volume: 35, Issue:7 Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Liposomes; Male; Meningeal Neoplasms; Meningitis	2011
Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization. Acta pharmacologica Sinica, 2011, Volume: 32, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Cholic Acid; Chromatography, Liquid; Cytarabine; Drug Delivery Systems; Half-Life; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Liver; Male; Mass Spectrometry; Mice; Rats; Rats, Sprague-Dawley; Tissue Distribution	2011
Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia. The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Neoplastic; Tretinoin	2011
Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy. Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Leukostasis; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Tumor Lysis Syndrome; Young Adult	2011
miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:4 Topics: 3' Untranslated Regions; Antimetabolites, Antineoplastic; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspases; Cell Survival; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; HEK293 Cells; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sequence Homology, Nucleic Acid	2012
Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine. Leukemia research, 2012, Volume: 36, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Oxides; Primary Myelofibrosis; Remission Induction; Survivors; Tretinoin	2012
Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia. Cancer science, 2012, Volume: 103, Issue:11 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Japan; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Recurrence; Treatment Outcome; Tretinoin	2012
Gemtuzumab ozogamicin: time to resurrect? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-10, Volume: 30, Issue:32 Topics: Age Factors; Aged; Aminoglycosides; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Drug Approval; Gemtuzumab; Humans; Immunotoxins; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Middle Aged; Treatment Outcome; United States; United States Food and Drug Administration	2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group. Annals of hematology, 2013, Volume: 92, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Leukocyte Count; Maintenance Chemotherapy; Male; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Oxides; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Risk; Thioguanine; Treatment Outcome; Tretinoin	2013
Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia. Blood, 2013, Feb-14, Volume: 121, Issue:7 Topics: Animals; Anthracyclines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; CD11b Antigen; CD11c Antigen; Cell Line, Tumor; Cytarabine; Fluorescent Dyes; Green Fluorescent Proteins; HL-60 Cells; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Luminescent Measurements; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Optical Imaging; Tretinoin; Valproic Acid; Xenograft Model Antitumor Assays	2013
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells. Biochemical pharmacology, 2002, Aug-01, Volume: 64, Issue:3 Topics: Apoptosis; Arabinofuranosylcytosine Triphosphate; Benzamidines; Cell Division; Cytarabine; DNA; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases	2002
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukem Experimental hematology, 2002, Volume: 30, Issue:11 Topics: Antineoplastic Agents; Catalysis; Cell Cycle; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytarabine; Daunorubicin; Deoxycytidine; Diketopiperazines; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Granulocytes; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplastic Stem Cells; Piperazines; Razoxane; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; RNA, Messenger; RNA, Neoplasm; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured; U937 Cells	2002
Pharmacokinetics of a standard dose of cytarabine in a patient with acute promyelocytic leukemia undergoing continuous ambulatory peritoneal dialysis. International journal of hematology, 2003, Volume: 77, Issue:2 Topics: Adult; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Peritoneal Dialysis, Continuous Ambulatory; Pharmacokinetics; Radioimmunoassay	2003
All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Death; Cytarabine; Drug Interactions; Genes, bcl-2; Leukemia, Promyelocytic, Acute; Nucleoside Transport Proteins; Tretinoin; Tumor Cells, Cultured	2003
Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia. Leukemia & lymphoma, 2003, Volume: 44, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Reverse Transcriptase Polymerase Chain Reaction; Tomography, X-Ray Computed; Treatment Outcome; Tretinoin	2003
[Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Daunorubicin; Female; Humans; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Remission Induction; Tretinoin	2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia, 2003, Volume: 17, Issue:8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Cytogenetic Analysis; Female; Follow-Up Studies; Humans; Incidence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Retrospective Studies; Tretinoin	2003
Acute arterial thrombosis in acute promyelocytic leukaemia. Clinical and laboratory haematology, 2003, Volume: 25, Issue:4 Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cysteine Endopeptidases; Cytarabine; Daunorubicin; Female; Gangrene; Humans; Intermittent Claudication; Ischemia; Leg; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Popliteal Artery; Remission Induction; Smoking; Thioguanine; Thrombophilia; Thromboplastin; Thrombosis; Toes; Tretinoin	2003
Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid. Leukemia & lymphoma, 2003, Volume: 44, Issue:9 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Pulmonary Embolism; Purpura, Thrombotic Thrombocytopenic; Remission Induction; Tretinoin	2003
MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia. International journal of hematology, 2003, Volume: 78, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Cytarabine; Daunorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Topoisomerase II Inhibitors; Translocation, Genetic; Tretinoin	2003
Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Haematologica, 2004, Volume: 89, Issue:1 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous	2004
Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML). Annals of hematology, 2005, Volume: 84, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic	2005
A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment. Acta medica Okayama, 2004, Volume: 58, Issue:5 Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Epidural Space; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Sarcoma, Myeloid; Spinal Neoplasms; Thoracic Vertebrae	2004
Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:2 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hypertriglyceridemia; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pancreatitis; Tretinoin	2005
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Experimental hematology, 2005, Volume: 33, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Cytarabine; Deoxyribonucleotides; DNA; Drug Synergism; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Ribonucleotide Reductases; Stilbenes	2005
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. Haematologica, 2005, Volume: 90, Issue:5 Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Cell Differentiation; Cell Membrane; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; GPI-Linked Proteins; Granulocytes; HL-60 Cells; Humans; Hydroxyurea; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Monocytes; Oncogene Proteins, Fusion; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Recombinant Fusion Proteins; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor Decoy Receptors; Tumor Stem Cell Assay; U937 Cells	2005
Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Liver Transplantation; Living Donors; Ornithine Carbamoyltransferase Deficiency Disease; Remission Induction; Tacrolimus; Tretinoin	2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Pleural Neoplasms; Tomography, X-Ray Computed	2006
[Adams-Stokes attack due to complete atrioventricular block in a patient with acute promyelocytic leukemia during remission induction therapy using all-trans retinoic acid]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Heart Block; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Pacemaker, Artificial; Remission Induction; Tretinoin	2005
Shifting to outpatient management of acute myeloid leukemia: a prospective experience. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Feasibility Studies; Female; Humans; Inpatients; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Outpatients; Patient Discharge; Patient Readmission; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome	2006
Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells. Molecular cancer therapeutics, 2006, Volume: 5, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase Inhibitors; Caspases; Cytarabine; Cytochromes a; Cytochromes c; Daunorubicin; Down-Regulation; Harringtonines; HL-60 Cells; Homoharringtonine; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proteasome Inhibitors; Protein Biosynthesis; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2	2006
Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia. Cancer genetics and cytogenetics, 2006, Volume: 167, Issue:2 Topics: Adult; Antineoplastic Agents; Chromosomes, Human, Pair 1; Cytarabine; Daunorubicin; Female; Humans; Isochromosomes; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Myelodysplastic Syndromes	2006
Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. Pediatric blood & cancer, 2007, Volume: 49, Issue:2 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Child; Child, Preschool; Chromosome Inversion; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Humans; Infant; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Prognosis; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Translocation, Genetic; WT1 Proteins	2007
Arsenic trioxide-responsive leukemia cutis in a patient with acute promyelocytic leukemia after ATRA treatment. Leukemia & lymphoma, 2006, Volume: 47, Issue:7 Topics: Adolescent; Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Oxides; Risk; Skin; Tretinoin	2006
Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases. European journal of haematology, 2006, Volume: 77, Issue:5 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytoprotection; Dexamethasone; Female; Glycine; Humans; Intracranial Hemorrhages; Leukemia, Promyelocytic, Acute; Male; Prospective Studies; Radiography; Randomized Controlled Trials as Topic; Remission Induction; Respiratory Distress Syndrome; Serine Proteinase Inhibitors; Sulfonamides; Tretinoin	2006
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Experimental hematology, 2006, Volume: 34, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxyribonucleotides; Drug Evaluation, Preclinical; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Pyrogallol; Resveratrol; Ribonucleotide Reductases; Ribonucleotides; Stilbenes; Tumor Necrosis Factor-alpha; Wine	2006
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells. Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescent Dyes; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Propidium; Pyrogallol; Stilbenes	2006
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Free Radical Scavengers; Free Radicals; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Stilbenes	2006
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:2 Topics: Anthracyclines; Antimetabolites, Antineoplastic; Boronic Acids; Bortezomib; Cell Cycle; Cell Survival; Cytarabine; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Protease Inhibitors; Pyrazines; Tumor Suppressor Protein p53	2007
Late relapses in acute promyelocytic leukaemia. Acta haematologica, 2007, Volume: 117, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Mastoid; Mitoxantrone; Recurrence; Time Factors; Tretinoin	2007
Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia. British journal of haematology, 2007, Volume: 137, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Oncogene Proteins, Fusion; Remission Induction; Translocation, Genetic; Tretinoin	2007
Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance. Leukemia & lymphoma, 2007, Volume: 48, Issue:3 Topics: Antineoplastic Agents; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Drug Resistance, Neoplasm; Female; Frameshift Mutation; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Middle Aged; Oncogene Proteins, Fusion; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Translocation, Genetic; Tretinoin	2007
Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia. The Malaysian journal of pathology, 2006, Volume: 28, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Primary Myelofibrosis	2006
[Effect of daunorubicin and cytarabine on cell line NB4]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2007, Volume: 28, Issue:4 Topics: Apoptosis; Cytarabine; Daunorubicin; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute	2007
All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure. Southern medical journal, 2007, Volume: 100, Issue:9 Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dyspnea; Female; Humans; Leukemia, Promyelocytic, Acute; Respiratory Insufficiency; Tretinoin	2007
[Studies of two conjugates of monoclonal antibody (HIM6) and cytosine arabinoside]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1993, Volume: 15, Issue:4 Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Cytarabine; Dextrans; Drug Carriers; Humans; Immunotoxins; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Polyglutamic Acid; Tumor Cells, Cultured	1993
[Pulmonary mucormycosis in leukemic patients. Apropos of 2 cases]. Sangre, 1994, Volume: 39, Issue:1 Topics: Adult; Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Itraconazole; Leukemia, Promyelocytic, Acute; Lung Diseases, Fungal; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Mucormycosis; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1994
Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid. Leukemia, 1994, Volume: 8, Issue:8 Topics: Adolescent; Adult; Bone Marrow; Cell Division; Chemotaxis; Child, Preschool; Cytarabine; Drug Interactions; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recombinant Proteins; Remission Induction; Tretinoin; Tumor Cells, Cultured	1994
All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. Leukemia, 1994, Volume: 8, Issue:12 Topics: Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Megakaryocytes; Tretinoin	1994
[Intermittent-dose ara-C/daunomycin therapy combined with cyclosporin-A and G-CSF led to a fourth remission in a patient with acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Recurrence; Remission Induction	1995
Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 1995, Sep-26, Volume: 92, Issue:20 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cyclin-Dependent Kinases; Cytarabine; DNA Damage; DNA, Neoplasm; Enzyme Induction; Enzyme Inhibitors; G1 Phase; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Marine Toxins; Oxazoles; Protein Tyrosine Phosphatases; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Zinc	1995
[Disease-free survival of acute leukemia patients receiving autologous bone marrow transplant following intensive chemotherapy--a report of 11 cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Thioguanine	1995
[Successful adjuvant therapy of M-CSF with chemotherapy of two cases of chemotherapy resistant acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:6 Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia, Promyelocytic, Acute; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Prednisolone; Remission Induction	1995
Selection and partial characterization of calcium ionophore (A23187) resistant cells. Biochemical and biophysical research communications, 1995, Aug-15, Volume: 213, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Calcimycin; Calcium; Cell Division; Cytarabine; DNA; Drug Resistance; Etoposide; Flow Cytometry; Humans; Ionomycin; Leukemia, Promyelocytic, Acute; Terpenes; Thapsigargin; Tumor Cells, Cultured; Ultraviolet Rays	1995
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood, 1995, Sep-01, Volume: 86, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Whole-Body Irradiation	1995
Sensitivity of hematopoietic progenitors of acute myeloblastic leukemia to new compounds derived from marine organisms. Leukemia, 1995, Volume: 9, Issue:9 Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cytarabine; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured; Urochordata	1995
Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia. Leukemia, 1995, Volume: 9, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Remission Induction; Thioguanine; Translocation, Genetic	1995
[Comparison of the sensitivity of retinoic acid sensitive and resistant HL-60 cell lines to several anti-leukemia drugs]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 1994, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Cytarabine; Drug Resistance; Drug Synergism; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Tretinoin; Tumor Cells, Cultured	1994
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. British journal of cancer, 1995, Volume: 71, Issue:5 Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deamination; DNA; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Microsomes, Liver; Tumor Cells, Cultured	1995
Rapid progression of 'retinoic acid syndrome' in the hypogranular variant of acute promyelocytic leukaemia, despite treatment with dexamethasone and conventional chemotherapy. Clinical and laboratory haematology, 1994, Volume: 16, Issue:4 Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Syndrome; Tretinoin	1994
Acute colonic pseudo-obstruction (Ogilvie's syndrome) during induction treatment with chemotherapy and all-trans-retinoic acid for acute promyelocytic leukemia. American journal of hematology, 1995, Volume: 49, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Pseudo-Obstruction; Cytarabine; Daunorubicin; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Middle Aged; Remission Induction; Tretinoin	1995
Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992. Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; British Columbia; Cytarabine; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195. Leukemia, 1995, Volume: 9, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Differentiation; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Idarubicin; Immunologic Factors; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Neutropenia; Nuclear Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Remission Induction; Salvage Therapy; Sialic Acid Binding Ig-like Lectin 3; Survival Analysis; Transcription Factors; Treatment Outcome; Tretinoin; Tumor Suppressor Proteins	1995
GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells. Leukemia, 1995, Volume: 9, Issue:3 Topics: Arabinofuranosylcytosine Triphosphate; Asparaginase; Cell Division; Cytarabine; DNA, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Neoplastic Stem Cells; S Phase; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995
Flow cytometric analysis of the cell cycle of the leukemic cell lines treated with etoposide and cytosine arabinoside. The Tohoku journal of experimental medicine, 1994, Volume: 174, Issue:2 Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Cytarabine; DNA Replication; DNA, Neoplasm; Etoposide; Flow Cytometry; Humans; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured	1994
Toxicity of tretinoin in acute promyelocytic leukaemia. Lancet (London, England), 1994, Feb-05, Volume: 343, Issue:8893 Topics: Child, Preschool; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Leukocytosis; Papilledema; Remission Induction; Tretinoin	1994
Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood, 1994, Oct-01, Volume: 84, Issue:7 Topics: Acetamides; Butyrates; Cell Differentiation; Cholecalciferol; Cytarabine; Drug Synergism; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Tretinoin; Tumor Cells, Cultured	1994
Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncology research, 1994, Volume: 6, Issue:2 Topics: Alkaloids; Apoptosis; Arabinofuranosylcytosine Triphosphate; Cytarabine; DNA Damage; Drug Synergism; Gene Expression; Genes, jun; Humans; Leukemia, Promyelocytic, Acute; Protein Kinase C; Staurosporine; Tumor Cells, Cultured	1994
Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochemical pharmacology, 1994, Nov-16, Volume: 48, Issue:10 Topics: Acetylcysteine; Apoptosis; Base Sequence; Cytarabine; Endonucleases; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; NF-kappa B; Oligodeoxyribonucleotides; Phenanthrolines; Pyrrolidines; T-Lymphocytes; Thiocarbamates; Thymus Gland; Tumor Cells, Cultured	1994
A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features. Leukemia, 1994, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thioguanine; Translocation, Genetic	1994
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy]. Deutsche medizinische Wochenschrift (1946), 1994, Aug-26, Volume: 119, Issue:34-35 Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Danazol; Drug Evaluation; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Tamoxifen; Time Factors; Tretinoin	1994
[Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Infarction; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Tretinoin	1994
[Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Sangre, 1993, Volume: 38, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation Tests; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Plasma; Platelet Transfusion; Remission Induction; Treatment Outcome	1993
1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. The Journal of biological chemistry, 1994, Jun-03, Volume: 269, Issue:22 Topics: Cell Differentiation; Cell Line; Ceramides; Cytarabine; Diglycerides; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Kinetics; Leukemia, Promyelocytic, Acute; NF-kappa B; Sphingomyelin Phosphodiesterase; Time Factors; Tumor Cells, Cultured	1994
Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse. The Clinical investigator, 1993, Volume: 71, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Isotretinoin; Leukemia, Promyelocytic, Acute; Middle Aged; Recurrence; Remission Induction; Tretinoin	1993
[Combination induction of cell differentiation of HL-60 cells by daidzein (S86019) and BC-4 or Ara-C]. Yao xue xue bao = Acta pharmaceutica Sinica, 1993, Volume: 28, Issue:1 Topics: Cell Cycle; Cell Differentiation; Cell Division; Cytarabine; Drug Synergism; Drugs, Chinese Herbal; Humans; Isoflavones; Leukemia, Promyelocytic, Acute; Phagocytosis; Tumor Cells, Cultured	1993
Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Medical and pediatric oncology, 1993, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Histiocytosis, Langerhans-Cell; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Male; Prednisolone; Vinblastine; Vincristine	1993
t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse. Leukemia & lymphoma, 1995, Volume: 19, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome Mapping; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 6; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Polymerase Chain Reaction; Recurrence; Translocation, Genetic; Tretinoin	1995
Continued complete remission after a PML/RAR-alpha+ autograft in acute promyelocytic leukaemia. European journal of haematology, 1996, Volume: 56, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Cytarabine; Doxorubicin; Female; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Remission Induction; Transplantation, Autologous; Tretinoin	1996
All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia. Medical and pediatric oncology, 1996, Volume: 26, Issue:4 Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents; Child, Preschool; Critical Illness; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Remission Induction; Syndrome; Tretinoin	1996
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri. British journal of haematology, 1996, Volume: 92, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Blotting, Southern; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Polymerase Chain Reaction; Pseudotumor Cerebri; Skin Neoplasms; Tretinoin	1996
Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells. Leukemia, 1996, Volume: 10, Issue:7 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bryostatins; Calcium; Cell Adhesion; Cell Cycle; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytarabine; DNA Damage; Drug Synergism; Ethylenes; HL-60 Cells; Humans; Lactones; Leukemia, Promyelocytic, Acute; Macrolides; Macrophage-1 Antigen; Protein Kinase C; Proto-Oncogene Proteins c-myc; Tumor Stem Cell Assay	1996
Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:5 Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Differentiation; Cell Division; Cytarabine; Cytotoxins; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tumor Cells, Cultured	1996
The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia. Chinese medical journal, 1996, Volume: 109, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Melphalan; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1996
Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood, 1996, Sep-01, Volume: 88, Issue:5 Topics: Adult; Antineoplastic Agents; Cell Differentiation; Cell Division; Chromosome Aberrations; Cytarabine; Daunorubicin; DNA Mutational Analysis; Drug Resistance, Neoplasm; Fatal Outcome; Female; HL-60 Cells; Humans; Immunophenotyping; Karyotyping; Leukemia, Promyelocytic, Acute; Mercaptopurine; Neoplasm Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prednisolone; Tretinoin; Tumor Cells, Cultured	1996
Differentiation induction therapy with all-trans retinoic acid (ATRA) in a patient with secondary 11q23 leukemia. Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 11; Cytarabine; Drug Resistance, Multiple; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Translocation, Genetic; Tretinoin	1996
Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases. European journal of obstetrics, gynecology, and reproductive biology, 1995, Volume: 63, Issue:2 Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Promyelocytic, Acute; Mitoxantrone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Recurrence; Thioguanine	1995
Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines. The European respiratory journal, 1997, Volume: 10, Issue:5 Topics: Anthracyclines; Antimetabolites, Antineoplastic; Bronchial Diseases; Child; Cryptogenic Organizing Pneumonia; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Lung; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Translocation, Genetic	1997
Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid. Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7 Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cytarabine; Daunorubicin; Ear Canal; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Radiotherapy; Recurrence; Remission Induction; Salvage Therapy; Tretinoin; Vindesine	1997
Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood, 1997, Aug-01, Volume: 90, Issue:3 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplasm, Residual; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prognosis; Prospective Studies; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Tretinoin	1997
[Successful treatment of subdural hematoma with operation in a patient with acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Hematoma, Subdural; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin	1997
Comparing an apple to a fruit salad. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8 Topics: Antimetabolites, Antineoplastic; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Research Design	1997
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid. Experimental hematology, 1997, Volume: 25, Issue:12 Topics: Adenosine; Adenosylhomocysteinase; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Granulocytes; Humans; Hydrolases; Leukemia, Promyelocytic, Acute; Leukopoiesis; Tretinoin; Tumor Cells, Cultured	1997
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome; Tretinoin	1998
Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood, 1998, Mar-01, Volume: 91, Issue:5 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cysteine Endopeptidases; Cytarabine; Cytochrome c Group; Enzyme Activation; Etoposide; Fusion Proteins, bcr-abl; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sphingolipids; Transfection; Tumor Cells, Cultured	1998
[Consolidation therapy with high-dose cytarabine and daunorubicin for prolonged disease free survival in acute myelocytic leukemia]. Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged	1996
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. Leukemia, 1998, Volume: 12, Issue:9 Topics: Adult; Aged; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cytarabine; Daunorubicin; Female; Heart; Heart Failure; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Tretinoin	1998
[Clinical significance of detection of PML-RAR alpha fusion gene of APL during differentiation therapy with ATRA]. Zhonghua yi xue za zhi, 1997, Volume: 77, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cloning, Molecular; Cytarabine; Female; Follow-Up Studies; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Oncogene Proteins, Fusion; Tretinoin	1997
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer, 1998, Oct-15, Volume: 83, Issue:8 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Gene Amplification; Gene Rearrangement; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Skin Neoplasms; Translocation, Genetic; Tretinoin	1998
Management of acute promyelocytic leukemia relapse in the ATRA era. Haematologica, 1998, Volume: 83, Issue:8 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Salvage Therapy; Thioguanine; Treatment Outcome; Tretinoin	1998
In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:12 Pt 1 Topics: Animals; Cytarabine; Diphtheria Toxin; Disease-Free Survival; Doxorubicin; Female; HL-60 Cells; Humans; Immunotoxins; Leukemia, Promyelocytic, Acute; Macaca fascicularis; Mice; Mice, SCID; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Recombinant Fusion Proteins; Tissue Distribution; Transplantation, Heterologous	1997
Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization. Haematologica, 1999, Volume: 84, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Tretinoin	1999
Early detection by ultrasound scan of severe post-chemotherapy gut complications in patients with acute leukemia. Haematologica, 1999, Volume: 84, Issue:3 Topics: Acute Disease; Adult; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dilatation, Pathologic; Enterocolitis; Etoposide; Female; Gallbladder Diseases; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Intubation, Gastrointestinal; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Ultrasonography	1999
Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995. Annals of hematology, 1999, Volume: 78, Issue:3 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Chromosome Aberrations; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Remission Induction; Retinoids; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Survival Rate; Time Factors; United Kingdom	1999
Long-term molecular remission in promyelocytic transformation of myeloproliferative disease. Leukemia, 1999, Volume: 13, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Polycythemia Vera; Preleukemia; Prognosis; Remission Induction; Thrombocythemia, Essential; Thrombophilia; Translocation, Genetic; Tretinoin	1999
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia. Genes, chromosomes & cancer, 2000, Volume: 27, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Exons; Fatal Outcome; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Tretinoin	2000
[Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:10 Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Daunorubicin; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome; Tretinoin	1999
Acute promyelocytic leukemia with del(6)(p23). Leukemia research, 2000, Volume: 24, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 6; Cytarabine; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Oncogene Proteins, Fusion; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Tretinoin	2000
Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose ara-C and maintenance with intermittent all-trans retinoic acid (ATRA). Leukemia & lymphoma, 2000, Volume: 36, Issue:5-6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Remission Induction; Time Factors; Tretinoin	2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia, 2000, Volume: 14, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Tretinoin	2000
Interferon may reduce minimal residual disease of acute promyelocytic leukemia. Leukemia, 2000, Volume: 14, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Interferons; Leukemia, Promyelocytic, Acute; Neoplasm, Residual; Recurrence; Remission Induction; Tretinoin	2000
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment. Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Cytarabine; Daunorubicin; Dyspnea; Fatal Outcome; Fever; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Middle Aged; Pulmonary Alveoli; Remission Induction; Syndrome; Tretinoin	2000
Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia. Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Femur Head Necrosis; Humans; Leukemia, Promyelocytic, Acute; Male; Tretinoin	2000
Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. Cancer research, 2001, Jan-01, Volume: 61, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Female; Growth Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin; Tumor Cells, Cultured; U937 Cells	2001
[Acute myeloid leukemia in the adult. Results of the National Antineoplastic Drug Protocol at the Hospital del Salvador, 1990-1998]. Revista medica de Chile, 2000, Volume: 128, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Retrospective Studies; Treatment Outcome	2000
Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case. Annals of hematology, 2001, Volume: 80, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 22; Cytarabine; Humans; Idarubicin; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Kidney Transplantation; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Polycystic Kidney Diseases; Recurrence; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Tretinoin	2001
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy. British journal of haematology, 2001, Volume: 114, Issue:3 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Cytarabine; Deoxycytidine Kinase; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute	2001
Acute arterial occlusion as the presenting feature in acute promyelocytic leukaemia. British journal of haematology, 2001, Volume: 115, Issue:1 Topics: Amputation, Surgical; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cytarabine; Daunorubicin; Female; Foot Diseases; Heparin; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Necrosis; Popliteal Artery; Thioguanine; Tretinoin	2001
Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia. Leukemia, 2001, Volume: 15, Issue:12 Topics: Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Promyelocytic, Acute; Treatment Outcome	2001
Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia. American journal of hematology, 2002, Volume: 69, Issue:1 Topics: Aged; Antineoplastic Agents; CD56 Antigen; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 8; Cytarabine; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Prognosis; Recombinant Proteins; Recurrence; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic	2002
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Piperazines; Prednisolone; Remission Induction; Tretinoin; Vincristine	2002
Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. European journal of haematology, 2001, Volume: 67, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Hyperplasia; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Radiography; Sweet Syndrome; Thymus Gland; Tretinoin	2001
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine	2001
Automated differential counts in acute promyelocytic leukemia patients may be misleading. Medical and pediatric oncology, 2002, Volume: 38, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cytarabine; Diagnostic Errors; Eosinophils; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Tretinoin	2002
Patchy polyneuropathy in acute promyelocytic leukaemia. Clinical and laboratory haematology, 1992, Volume: 14, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Remission Induction; Translocation, Genetic; Transplantation, Homologous	1992
[Auer rods-positive neutrophils observed at diagnosis increased after remission induction in patient with acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; Humans; Inclusion Bodies; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Neutrophils; Prednisolone; Remission Induction	1992
Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. Cancer research, 1992, Nov-15, Volume: 52, Issue:22 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bryostatins; Calcitriol; Cytarabine; DNA; DNA Damage; DNA, Neoplasm; Drug Synergism; Humans; Lactones; Leukemia, Promyelocytic, Acute; Macrolides; NAD; Protein Kinase C; Thymidine; Time Factors; Tritium; Tumor Cells, Cultured	1992
Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells. Experimental cell research, 1992, Volume: 203, Issue:1 Topics: Biological Transport; Calcitriol; Cell Differentiation; Cell Division; Cell Survival; Clone Cells; Cytarabine; Deoxycytidine Kinase; Drug Resistance; Gene Expression; Genes, myc; Genetic Variation; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Monocytes; Oligonucleotide Probes; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured	1992
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood, 1992, Dec-01, Volume: 80, Issue:11 Topics: Actins; Apoptosis; Blotting, Northern; Cell Death; Cytarabine; Drug Synergism; Genes, jun; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; GTP-Binding Proteins; Humans; Interleukin-3; Kinetics; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogenes; Recombinant Fusion Proteins; RNA, Neoplasm; Tumor Cells, Cultured	1992
Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms. Cytometry, 1992, Volume: 13, Issue:7 Topics: Bromodeoxyuridine; Cytarabine; DNA Replication; DNA, Neoplasm; Drug Resistance; Humans; Leukemia, Promyelocytic, Acute; Male; Software; Tumor Cells, Cultured	1992
[Two cases of acute promyelocytic leukemia in pregnancy and the effect of anthracyclines on fetal development]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Embryonic and Fetal Development; Female; Fetal Death; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Prednisolone; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic	1992
[A case report of an acute promyelocytic leukemia patient showing remarkable thrombopoiesis prior to granulopoiesis by hM-CSF treatment after chemotherapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Granulocytes; Hematopoiesis; Humans; Leukemia, Promyelocytic, Acute; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Mitoxantrone	1992
Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood, 1992, Apr-15, Volume: 79, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Cytarabine; Daunorubicin; DNA, Neoplasm; Etoposide; Female; Genetic Linkage; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic; Tretinoin; X Chromosome	1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leukemia research, 1992, Volume: 16, Issue:5 Topics: Acute Disease; Cell Division; Cytarabine; Drug Synergism; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quercetin; Receptors, Estrogen; Tumor Cells, Cultured; Tumor Stem Cell Assay	1992
High interleukin-6 plasma levels in acute promyelocytic leukemia. Annals of hematology, 1992, Volume: 64, Issue:6 Topics: Cytarabine; Drug Therapy, Combination; Humans; Idarubicin; Interleukin-6; Leukemia, Promyelocytic, Acute; Osmolar Concentration; Time Factors	1992
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs. Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:2 Topics: Adult; Aged; Cytarabine; Daunorubicin; Deoxycytidine; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tumor Cells, Cultured	1991
[Focal hepato-splenic mycosis caused by Trichosporon beigelii in a patient with acute leukemia]. Sangre, 1991, Volume: 36, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease Susceptibility; Hepatitis; Humans; Immunocompromised Host; Leukemia, Promyelocytic, Acute; Male; Mycoses; Opportunistic Infections; Splenic Diseases; Trichosporon	1991
The impact of selected nucleosides on the cytotoxicity of Ara-C in HL60 cells. Advances in experimental medicine and biology, 1991, Volume: 309A Topics: Cell Line; Cell Survival; Cytarabine; Cytidine; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Drug Interactions; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Nucleosides; Tetrahydrouridine; Uridine	1991
Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid. Leukemia research, 1991, Volume: 15, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Stereoisomerism; Tretinoin	1991
Regulation of c-jun gene expression in HL-60 leukemia cells by 1-beta-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism. Biochemistry, 1991, Aug-13, Volume: 30, Issue:32 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aphidicolin; Cell Line; Cell Nucleus; Cycloheximide; Cytarabine; Dactinomycin; Diterpenes; DNA-Binding Proteins; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Kinetics; Leukemia, Promyelocytic, Acute; Piperazines; Protein Kinase C; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-jun; Proto-Oncogenes; RNA, Neoplasm; Sulfonamides; Transcription Factors; Transcription, Genetic	1991
Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine. International journal of cancer, 1991, Oct-21, Volume: 49, Issue:4 Topics: 3-Deazauridine; Cell Line; Cell Survival; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute	1991
Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia. Medical and pediatric oncology, 1991, Volume: 19, Issue:2 Topics: Adolescent; Bulbar Palsy, Progressive; Cerebellar Ataxia; Child; Cytarabine; Female; Humans; Injections, Intravenous; Jaundice; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Paralysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma	1991
Jaundice and hepatorenal syndrome associated with cytosine arabinoside. Journal of the National Medical Association, 1990, Volume: 82, Issue:3 Topics: Acute Kidney Injury; Adult; Chemical and Drug Induced Liver Injury; Cytarabine; Humans; Hyperbilirubinemia; Leukemia, Promyelocytic, Acute; Liver Diseases; Male	1990
Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer research, 1990, May-01, Volume: 50, Issue:9 Topics: Arabinonucleotides; Cytarabine; Cytidine Monophosphate; DNA Replication; DNA, Neoplasm; Humans; Hydrogen-Ion Concentration; Kinetics; Leukemia, Promyelocytic, Acute; Thymidine; Tumor Cells, Cultured	1990
[Multiple liver abscesses due to Candida albicans in a patient with acute promyelocytic leukemia: percutaneous transhepatic intraportal administration of amphotericin B]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:3 Topics: Adult; Amphotericin B; Candidiasis; Catheterization; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Liver Abscess; Male; Portal System	1990
[Complete remission without marrow aplasia phase in a patient with acute promyelocytic leukosis treated with aggressive chemotherapy]. Anales de medicina interna (Madrid, Spain : 1984), 1989, Volume: 6, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Differentiation; Cytarabine; Disseminated Intravascular Coagulation; Doxorubicin; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplastic Stem Cells; Prednisolone; Remission Induction; Time Factors; Vincristine	1989
Synergistic effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on the generation of DNA strand breaks in a human promyelocytic leukemia cell line. Leukemia research, 1989, Volume: 13, Issue:2 Topics: Aphidicolin; Cell Line; Cytarabine; Diterpenes; DNA Damage; Drug Combinations; Drug Synergism; Humans; Hypoxanthine; Hypoxanthines; Leucovorin; Leukemia, Promyelocytic, Acute; Methotrexate; Phosphorylation; Thymidine	1989
Cell cycle related change of Ara-C transport in HL-60 cells after differentiation induction. FEBS letters, 1989, Apr-24, Volume: 247, Issue:2 Topics: Aphidicolin; Biological Transport; Cell Cycle; Cell Differentiation; Cell Membrane; Cytarabine; Deoxycytidine Kinase; Diterpenes; Humans; Interphase; Leukemia, Promyelocytic, Acute; Mutation; Tretinoin; Tumor Cells, Cultured	1989
Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside. American journal of hematology, 1989, Volume: 32, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Demyelinating Diseases; Horner Syndrome; Humans; Leukemia, Promyelocytic, Acute; Male; Peripheral Nervous System Diseases	1989
Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase. Advances in experimental medicine and biology, 1989, Volume: 253B Topics: Bone Marrow; Bone Marrow Cells; Cell Division; Cytarabine; Cytidine; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; Humans; Leukemia, Promyelocytic, Acute; Nucleoside Deaminases; Phosphotransferases; Tetrahydrouridine; Tretinoin; Tumor Cells, Cultured	1989
Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cells. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:11 Topics: Cell Differentiation; Cell Line; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured	1989
[Methicillin-resistant staphylococcal enterocolitis developed after induction chemotherapy in a case of acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enterocolitis; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methicillin; Middle Aged; Penicillin Resistance; Prednisolone; Remission Induction; Staphylococcal Infections; Staphylococcus aureus	1989
[Relapse of gingival tumor during hematological remission in acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Gingival Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Recurrence; Remission Induction; Vinblastine; Vincristine	1989
Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line. Advances in experimental medicine and biology, 1989, Volume: 253B Topics: Arabinofuranosylcytosine Triphosphate; Cycloheximide; Cytarabine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Hypoxanthine; Hypoxanthines; Leucovorin; Leukemia, Promyelocytic, Acute; Methotrexate; Thymidine; Tumor Cells, Cultured	1989
Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines. Advances in experimental medicine and biology, 1989, Volume: 253B Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Deoxycytidine; Deoxycytosine Nucleotides; Drug Synergism; Humans; Hydroxyurea; Leukemia; Leukemia, Promyelocytic, Acute; Methotrexate; Thymine Nucleotides; Tumor Cells, Cultured	1989
Characterization of nucleoside transport during leukemic cell differentiation. Advances in experimental medicine and biology, 1989, Volume: 253B Topics: Biological Transport; Cell Differentiation; Cytarabine; Deoxycytidine Kinase; Dipyridamole; Humans; Inosine; Leukemia, Promyelocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thioinosine; Tretinoin; Tumor Cells, Cultured	1989
[The successful surgery of lung abscess formed from pulmonary aspergilloma in a patient with recurrence of acute promyelocytic leukemia during remission induction therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:1 Topics: Adult; Aspergillosis; Cytarabine; Female; Humans; Leukemia, Promyelocytic, Acute; Lung Abscess; Lung Diseases, Fungal; Pneumonectomy; Recurrence; Remission Induction	1989
[4'-(9-acridinylamino)-methanesulfon-m-aniside (AMSA) combination salvage therapy in refractory acute non-lymphocytic leukemia in adults]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:5 Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukopenia; Male; Middle Aged; Prednisolone; Remission Induction; Thioguanine; Thrombocytopenia	1989
[Acute leukemia complicated by hyperbilirubinemia due to high dose cytosine arabinoside therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:2 Topics: Cholestasis, Intrahepatic; Cytarabine; Humans; Hyperbilirubinemia; Leukemia, Promyelocytic, Acute; Male; Middle Aged	1989
[Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols]. Medicina clinica, 1989, Apr-29, Volume: 92, Issue:16 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prednisolone; Prognosis; Remission Induction; Vincristine	1989
A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4 Topics: Arabinofuranosylcytosine Triphosphate; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; DNA; DNA Ligases; DNA Polymerase II; DNA, Neoplasm; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Tumor Stem Cell Assay	1989
Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings. AJR. American journal of roentgenology, 1989, Volume: 152, Issue:2 Topics: Atrophy; Cerebellar Diseases; Cerebellum; Child, Preschool; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed	1989
Treatment of acute promyelocytic leukemia. Blood, 1989, Volume: 74, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Promyelocytic, Acute	1989
[Successful treatment by a drainage of subdural hematoma in a case of intracranial hemorrhage due to DIC complicated with acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Drainage; Female; Hematoma, Subdural; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Prednisolone; Remission Induction	1989
Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro. Leukemia research, 1988, Volume: 12, Issue:10 Topics: Acetamides; Alkaloids; Cell Differentiation; Cell Division; Cytarabine; Doxorubicin; Drug Interactions; Female; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Software; Tumor Cells, Cultured	1988
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations. Pathology, research and practice, 1988, Volume: 184, Issue:1 Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Melanoma; Neoplasms; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured	1988
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity. The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4 Topics: Antimetabolites, Antineoplastic; Cell Line; Cytarabine; Daunorubicin; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Methotrexate; Tumor Cells, Cultured	1988